Hypothesis‐driven investigations of diverse pharmacological targets in two mouse models of autism

Maya A. Rhine; Jennifer M. Parrott; Maria N. Schultz; Tatiana M. Kazdoba; Jacqueline N. Crawley

doi:10.1002/aur.2066

Loading next page...

References (248)

( Wang, W. , Li, C. , Chen, Q. , van der Goes, M. S. , Hawrot, J. , Yao, A. Y. , … Feng, G. (2017). Striatopallidal dysfunction underlies repetitive behavior in Shank3‐deficient model of autism. The Journal of Clinical Investigation, 127, 1978–1990.28414301)
Wang, W. , Li, C. , Chen, Q. , van der Goes, M. S. , Hawrot, J. , Yao, A. Y. , … Feng, G. (2017). Striatopallidal dysfunction underlies repetitive behavior in Shank3‐deficient model of autism. The Journal of Clinical Investigation, 127, 1978–1990.28414301
Wang, W. , Li, C. , Chen, Q. , van der Goes, M. S. , Hawrot, J. , Yao, A. Y. , … Feng, G. (2017). Striatopallidal dysfunction underlies repetitive behavior in Shank3‐deficient model of autism. The Journal of Clinical Investigation, 127, 1978–1990.28414301, Wang, W. , Li, C. , Chen, Q. , van der Goes, M. S. , Hawrot, J. , Yao, A. Y. , … Feng, G. (2017). Striatopallidal dysfunction underlies repetitive behavior in Shank3‐deficient model of autism. The Journal of Clinical Investigation, 127, 1978–1990.28414301
( Bourgeron, T. (2009). A synaptic trek to autism. Current Opinion in Neurobiology, 19, 231–234.19545994)
Bourgeron, T. (2009). A synaptic trek to autism. Current Opinion in Neurobiology, 19, 231–234.19545994
Bourgeron, T. (2009). A synaptic trek to autism. Current Opinion in Neurobiology, 19, 231–234.19545994, Bourgeron, T. (2009). A synaptic trek to autism. Current Opinion in Neurobiology, 19, 231–234.19545994
H. McFarlane, G. Kusek, Mu Yang, J. Phoenix, V. Bolivar, V. Bolivar, J. Crawley (2008)
Autism‐like behavioral phenotypes in BTBR T+tf/J mice
Genes, 7
Silvia Rubeis, Xin He, A. Goldberg, Christopher Poultney, K. Samocha, A. Cicek, Y. Kou, Li Liu, M. Fromer, S. Walker, T. Singh, L. Klei, J. Kosmicki, Shih-Chen Fu, B. Aleksic, M. Biscaldi, P. Bolton, Jessica Brownfeld, Jinlu Cai, Nicholas Campbell, Á. Carracedo, Maria Chahrour, A. Chiocchetti, H. Coon, Emily Crawford, L. Crooks, S. Curran, G. Dawson, E. Duketis, B. Fernandez, L. Gallagher, Evan Geller, Stephen Guter, R. Hill, I. Ionita-Laza, P. González, H. Kilpinen, S. Klauck, A. Kolevzon, Irene Lee, Jing Lei, T. Lehtimäki, Chiao-Feng Lin, Avi Ma’ayan, C. Marshall, Alison McInnes, B. Neale, M. Owen, N. Ozaki, M. Parellada, J. Parr, S. Purcell, K. Puura, D. Rajagopalan, K. Rehnström, A. Reichenberg, A. Sabo, M. Sachse, Stephan Sanders, C. Schafer, M. Schulte-Rüther, D. Skuse, C. Stevens, P. Szatmari, K. Tammimies, O. Valladares, A. Voran, Li-San Wang, L. Weiss, A. Willsey, T. Yu, R. Yuen, E. Cook, C. Freitag, M. Gill, C. Hultman, T. Lehner, A. Palotie, G. Schellenberg, P. Sklar, M. State, J. Sutcliffe, C. Walsh, S. Scherer, M. Zwick, J. Barrett, D. Cutler, K. Roeder, B. Devlin, M. Daly, J. Buxbaum (2014)
Synaptic, transcriptional, and chromatin genes disrupted in autism
Nature, 515
Mehreen Kouser, Haley Speed, Colleen Dewey, Jeremy Reimers, A. Widman, N. Gupta, Shunan Liu, Thomas Jaramillo, M. Bangash, B. Xiao, P. Worley, C. Powell (2013)
Loss of Predominant Shank3 Isoforms Results in Hippocampus-Dependent Impairments in Behavior and Synaptic Transmission
The Journal of Neuroscience, 33
( Burket, J. A. , Benson, A. D. , Tang, A. H. , & Deutsch, S. I. (2014). Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)/J mouse model of autism spectrum disorders. Brain Research Bulletin, 100, 70–75.24295733)
Burket, J. A. , Benson, A. D. , Tang, A. H. , & Deutsch, S. I. (2014). Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)/J mouse model of autism spectrum disorders. Brain Research Bulletin, 100, 70–75.24295733
Burket, J. A. , Benson, A. D. , Tang, A. H. , & Deutsch, S. I. (2014). Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)/J mouse model of autism spectrum disorders. Brain Research Bulletin, 100, 70–75.24295733, Burket, J. A. , Benson, A. D. , Tang, A. H. , & Deutsch, S. I. (2014). Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)/J mouse model of autism spectrum disorders. Brain Research Bulletin, 100, 70–75.24295733
Cinzia Vicidomini, L. Ponzoni, Dmitry Lim, M. Schmeisser, D. Reim, Noemi Morello, Daniel Orelanna, A. Tozzi, Valentina Durante, P. Scalmani, M. Mantegazza, A. Genazzani, M. Giustetto, M. Sala, P. Calabresi, T. Boeckers, C. Sala, C. Verpelli (2016)
Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice
Molecular psychiatry, 22
( Massa, S. M. , Yang, T. , Xie, Y. , Shi, J. , Bilgen, M. , Joyce, J. N. , … Longo, F. M. (2010). Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. The Journal of Clinical Investigation, 120, 1774–1785.20407211)
Massa, S. M. , Yang, T. , Xie, Y. , Shi, J. , Bilgen, M. , Joyce, J. N. , … Longo, F. M. (2010). Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. The Journal of Clinical Investigation, 120, 1774–1785.20407211
Massa, S. M. , Yang, T. , Xie, Y. , Shi, J. , Bilgen, M. , Joyce, J. N. , … Longo, F. M. (2010). Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. The Journal of Clinical Investigation, 120, 1774–1785.20407211, Massa, S. M. , Yang, T. , Xie, Y. , Shi, J. , Bilgen, M. , Joyce, J. N. , … Longo, F. M. (2010). Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. The Journal of Clinical Investigation, 120, 1774–1785.20407211
( Bolivar, V. J. , Walters, S. R. , & Phoenix, J. L. (2007). Assessing autism‐like behavior in mice: Variations in social interactions among inbred strains. Behavioural Brain Research, 176, 21–26.17097158)
Bolivar, V. J. , Walters, S. R. , & Phoenix, J. L. (2007). Assessing autism‐like behavior in mice: Variations in social interactions among inbred strains. Behavioural Brain Research, 176, 21–26.17097158
Bolivar, V. J. , Walters, S. R. , & Phoenix, J. L. (2007). Assessing autism‐like behavior in mice: Variations in social interactions among inbred strains. Behavioural Brain Research, 176, 21–26.17097158, Bolivar, V. J. , Walters, S. R. , & Phoenix, J. L. (2007). Assessing autism‐like behavior in mice: Variations in social interactions among inbred strains. Behavioural Brain Research, 176, 21–26.17097158
C. Frye, Danielle Llaneza (2010)
Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice
Physiology & Behavior, 100
J. Blundell, Cory Blaiss, M. Etherton, Felipe Espinosa, K. Tabuchi, Christopher Walz, M. Bolliger, T. Südhof, C. Powell (2010)
Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior
The Journal of Neuroscience, 30
( Castello, N. A. , Nguyen, M. H. , Tran, J. D. , Cheng, D. , Green, K. N. , & Laferla, F. M. (2014). 7,8‐Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease‐like neuronal loss. PLoS One, 9, e91453.24614170)
Castello, N. A. , Nguyen, M. H. , Tran, J. D. , Cheng, D. , Green, K. N. , & Laferla, F. M. (2014). 7,8‐Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease‐like neuronal loss. PLoS One, 9, e91453.24614170
Castello, N. A. , Nguyen, M. H. , Tran, J. D. , Cheng, D. , Green, K. N. , & Laferla, F. M. (2014). 7,8‐Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease‐like neuronal loss. PLoS One, 9, e91453.24614170, Castello, N. A. , Nguyen, M. H. , Tran, J. D. , Cheng, D. , Green, K. N. , & Laferla, F. M. (2014). 7,8‐Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease‐like neuronal loss. PLoS One, 9, e91453.24614170
Caitlin Daimon, J. Jasien, W. Wood, Yongqing Zhang, K. Becker, J. Silverman, J. Crawley, B. Martin, Stuart Maudsley (2015)
Hippocampal Transcriptomic and Proteomic Alterations in the BTBR Mouse Model of Autism Spectrum Disorder
Frontiers in Physiology, 6
Atsushi Sato, S. Kasai, Toshiyuki Kobayashi, Y. Takamatsu, O. Hino, K. Ikeda, M. Mizuguchi (2012)
Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex
Nature Communications, 3
Fredrick Henry, William Hockeimer, A. Chen, S. Mysore, M. Sutton (2017)
Mechanistic target of rapamycin is necessary for changes in dendritic spine morphology associated with long-term potentiation
Molecular Brain, 10
Mu Yang, O. Bozdagi, M. Scattoni, M. Wöhr, F. Roullet, Adam Katz, Danielle Abrams, David Kalikhman, Harrison Simon, L. Woldeyohannes, James Zhang, Mark Harris, Roheeni Saxena, J. Silverman, J. Buxbaum, J. Crawley (2012)
Reduced Excitatory Neurotransmission and Mild Autism-Relevant Phenotypes in Adolescent Shank3 Null Mutant Mice
The Journal of Neuroscience, 32
A. Benson, Jessica Burket, S. Deutsch (2013)
Balb/c mice treated with d-cycloserine arouse increased social interest in conspecifics
Brain Research Bulletin, 99
J. Olmos-Serrano, J. Corbin, Mark Burns (2011)
The GABAA Receptor Agonist THIP Ameliorates Specific Behavioral Deficits in the Mouse Model of Fragile X Syndrome
Developmental Neuroscience, 33
( Mei, Y. , Monteiro, P. , Zhou, Y. , Kim, J. A. , Gao, X. , Fu, Z. , & Feng, G. (2016). Adult restoration of Shank3 expression rescues selective autistic‐like phenotypes. Nature, 530, 481–484.26886798)
Mei, Y. , Monteiro, P. , Zhou, Y. , Kim, J. A. , Gao, X. , Fu, Z. , & Feng, G. (2016). Adult restoration of Shank3 expression rescues selective autistic‐like phenotypes. Nature, 530, 481–484.26886798
Mei, Y. , Monteiro, P. , Zhou, Y. , Kim, J. A. , Gao, X. , Fu, Z. , & Feng, G. (2016). Adult restoration of Shank3 expression rescues selective autistic‐like phenotypes. Nature, 530, 481–484.26886798, Mei, Y. , Monteiro, P. , Zhou, Y. , Kim, J. A. , Gao, X. , Fu, Z. , & Feng, G. (2016). Adult restoration of Shank3 expression rescues selective autistic‐like phenotypes. Nature, 530, 481–484.26886798
F. Stagni, A. Giacomini, S. Guidi, M. Emili, B. Uguagliati, M. Salvalai, V. Bortolotto, M. Grilli, R. Rimondini, R. Bartesaghi (2017)
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS
Experimental Neurology, 298
J. Peça, C. Feliciano, J. Ting, Wenting Wang, Michael Wells, T. Venkatraman, C. Lascola, Z. Fu, G. Feng (2011)
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Nature, 472
M. Bové, K. Ike, A. Eldering, B. Buwalda, S. Boer, M. Morgese, S. Schiavone, V. Cuomo, L. Trabace, M. Kas (2018)
The Visible Burrow System: A behavioral paradigm to assess sociability and social withdrawal in BTBR and C57BL/6J mice strains
Behavioural Brain Research, 344
( Peixoto, M. F. , Araujo, N. P. , Silva, R. H. , Castro, J. P. , Fukushiro, D. F. , Faria, R. R. , … Abílio, V. C. (2005). Effects of gabaergic drugs on reserpine‐induced oral dyskinesia. Behavioural Brain Research, 160, 51–59.15836900)
Peixoto, M. F. , Araujo, N. P. , Silva, R. H. , Castro, J. P. , Fukushiro, D. F. , Faria, R. R. , … Abílio, V. C. (2005). Effects of gabaergic drugs on reserpine‐induced oral dyskinesia. Behavioural Brain Research, 160, 51–59.15836900
Peixoto, M. F. , Araujo, N. P. , Silva, R. H. , Castro, J. P. , Fukushiro, D. F. , Faria, R. R. , … Abílio, V. C. (2005). Effects of gabaergic drugs on reserpine‐induced oral dyskinesia. Behavioural Brain Research, 160, 51–59.15836900, Peixoto, M. F. , Araujo, N. P. , Silva, R. H. , Castro, J. P. , Fukushiro, D. F. , Faria, R. R. , … Abílio, V. C. (2005). Effects of gabaergic drugs on reserpine‐induced oral dyskinesia. Behavioural Brain Research, 160, 51–59.15836900
O. Bozdagi, T. Sakurai, Danae Papapetrou, Xiaobin Wang, D. Dickstein, N. Takahashi, Y. Kajiwara, Mu Yang, Adam Katz, M. Scattoni, Mark Harris, Roheeni Saxena, J. Silverman, J. Crawley, Qiang Zhou, P. Hof, J. Buxbaum (2010)
Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication
Molecular Autism, 1
H. Möhler (2015)
The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in Down syndrome and social interaction in autism.
Advances in pharmacology, 72
N. White, Manooj Prasad, R. Barfield, J. Nyby (1998)
40- and 70-kHz Vocalizations of Mice (Mus musculus) during Copulation
Physiology & Behavior, 63
(2015)
Synapse assembly and neurodevelopmental
( Monteiro, P. , & Feng, G. (2017). SHANK proteins: Roles at the synapse and in autism spectrum disorder. Nature Reviews. Neuroscience, 18, 147–157.28179641)
Monteiro, P. , & Feng, G. (2017). SHANK proteins: Roles at the synapse and in autism spectrum disorder. Nature Reviews. Neuroscience, 18, 147–157.28179641
Monteiro, P. , & Feng, G. (2017). SHANK proteins: Roles at the synapse and in autism spectrum disorder. Nature Reviews. Neuroscience, 18, 147–157.28179641, Monteiro, P. , & Feng, G. (2017). SHANK proteins: Roles at the synapse and in autism spectrum disorder. Nature Reviews. Neuroscience, 18, 147–157.28179641
( O'Roak, B. J. , Stessman, H. A. , Boyle, E. A. , Witherspoon, K. T. , Martin, B. , Lee, C. , … Eichler, E. E. (2014). Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nature Communications, 5, 5595.)
O'Roak, B. J. , Stessman, H. A. , Boyle, E. A. , Witherspoon, K. T. , Martin, B. , Lee, C. , … Eichler, E. E. (2014). Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nature Communications, 5, 5595.
O'Roak, B. J. , Stessman, H. A. , Boyle, E. A. , Witherspoon, K. T. , Martin, B. , Lee, C. , … Eichler, E. E. (2014). Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nature Communications, 5, 5595., O'Roak, B. J. , Stessman, H. A. , Boyle, E. A. , Witherspoon, K. T. , Martin, B. , Lee, C. , … Eichler, E. E. (2014). Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nature Communications, 5, 5595.
Andrew Holmes, R. Rodgers (1998)
Responses of Swiss–Webster Mice to Repeated Plus-Maze Experience Further Evidence for a Qualitative Shift in Emotional State?
Pharmacology Biochemistry and Behavior, 60
L. Devi, M. Ohno (2012)
7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's Disease
Neuropsychopharmacology, 37
E. Berry-Kravis, L. Lindemann, A. Jønch, George Apostol, M. Bear, Randall Carpenter, J. Crawley, A. Curie, V. Portes, F. Hossain, F. Gasparini, B. Gomez-Mancilla, D. Hessl, E. Loth, S. Scharf, Paul Wang, F. Raison, R. Hagerman, W. Spooren, S. Jacquemont (2017)
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
Nature Reviews Drug Discovery, 17
Sebastian Schade, W. Paulus (2015)
D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review
International Journal of Neuropsychopharmacology, 19
( De Rubeis, S. , He, X. , Goldberg, A. P. , Poultney, C. S., Samocha, K., Cicek, A. E., … Buxbaum, J. D. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature, 515, 209–215.25363760)
De Rubeis, S. , He, X. , Goldberg, A. P. , Poultney, C. S., Samocha, K., Cicek, A. E., … Buxbaum, J. D. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature, 515, 209–215.25363760
De Rubeis, S. , He, X. , Goldberg, A. P. , Poultney, C. S., Samocha, K., Cicek, A. E., … Buxbaum, J. D. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature, 515, 209–215.25363760, De Rubeis, S. , He, X. , Goldberg, A. P. , Poultney, C. S., Samocha, K., Cicek, A. E., … Buxbaum, J. D. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature, 515, 209–215.25363760
C. Verpelli, E. Dvoretskova, Cinzia Vicidomini, F. Rossi, M. Chiappalone, Michael Schoen, Bruno Stefano, R. Mantegazza, V. Broccoli, T. Böckers, Alexander Dityatev, C. Sala (2011)
Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses
The Journal of Biological Chemistry, 286
D. Pinto, Elsa Delaby, Elsa Delaby, Elsa Delaby, D. Merico, M. Barbosa, Alison Merikangas, L. Klei, B. Thiruvahindrapuram, Xiao Xu, Robert Ziman, Zhuozhi Wang, J. Vorstman, A. Thompson, R. Regan, R. Regan, M. Pilorge, M. Pilorge, M. Pilorge, G. Pellecchia, A. Pagnamenta, B. Oliveira, B. Oliveira, C. Marshall, T. Magalhães, T. Magalhães, J. Lowe, J. Howe, A. Griswold, J. Gilbert, E. Duketis, B. Dombroski, M. Jonge, M. Cuccaro, Emily Crawford, C. Correia, C. Correia, J. Conroy, Inȇs Conceição, Inȇs Conceição, A. Chiocchetti, J. Casey, J. Casey, Guiqing Cai, C. Cabrol, C. Cabrol, C. Cabrol, N. Bolshakova, E. Bacchelli, R. Anney, S. Gallinger, M. Cotterchio, G. Casey, L. Zwaigenbaum, Kerstin Wittemeyer, Kirsty Wing, S. Wallace, H. Engeland, A. Tryfon, Susanne Thomson, L. Soorya, B. Rogé, W. Roberts, F. Poustka, S. Mouga, N. Minshew, L. McInnes, S. McGrew, C. Lord, M. Leboyer, A. Couteur, A. Kolevzon, P. González, S. Jacob, S. Jacob, R. Holt, Stephen Guter, Jonathan Green, A. Green, Andrew Green, C. Gillberg, B. Fernandez, F. Duque, R. Delorme, G. Dawson, P. Chaste, C. Café, Sean Brennan, T. Bourgeron, P. Bolton, P. Bolton, S. Bölte, S. Bölte, R. Bernier, G. Baird, A. Bailey, A. Bailey, E. Anagnostou, J. Almeida, E. Wijsman, V. Vieland, A. Vicente, A. Vicente, G. Schellenberg, M. Pericak-Vance, A. Paterson, J. Parr, G. Oliveira, J. Nurnberger, A. Monaco, A. Monaco, E. Maestrini, S. Klauck, H. Hakonarson, J. Haines, D. Geschwind, C. Freitag, S. Folstein, S. Ennis, S. Ennis, H. Coon, A. Battaglia, P. Szatmari, J. Sutcliffe, Joachim Hallmayer, M. Gill, E. Cook, J. Buxbaum, B. Devlin, L. Gallagher, C. Betancur, C. Betancur, C. Betancur, S. Scherer (2014)
Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders
American Journal of Human Genetics, 94
G. Gould, A. Seillier, G. Weiss, A. Giuffrida, T. Burke, J. Hensler, Crystal Rock, Amanda Tristan, L. McMahon, A. Salazar, J. O'Connor, N. Satsangi, R. Satsangi, Ting-Ting Gu, Keenan Treat, Corey Smolik, S. Schultz (2012)
Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 38
Thomas Jaramillo, Haley Speed, Zhong Xuan, Jeremy Reimers, Christine Escamilla, Travis Weaver, Shunan Liu, I. Filonova, C. Powell (2017)
Novel Shank3 mutant exhibits behaviors with face validity for autism and altered striatal and hippocampal function
Autism Research, 10
Sung Han, Chao Tai, Christina Jones, T. Scheuer, W. Catterall (2014)
Enhancement of Inhibitory Neurotransmission by GABAA Receptors Having α2,3-Subunits Ameliorates Behavioral Deficits in a Mouse Model of Autism
Neuron, 81
Spyros Merkouris, Y. Barde, K. Binley, N. Allen, A. Stepanov, N. Wu, Geramie Grande, Chih-Wei Lin, M. Li, X. Nan, Pedro Chacón-Fernández, P. Distefano, R. Lindsay, R. Lerner, Jia Xie (2018)
Fully human agonist antibodies to TrkB using autocrine cell-based selection from a combinatorial antibody library
Proceedings of the National Academy of Sciences of the United States of America, 115
( Merkouris, S. , Barde, Y. , Binley, K. E. , Allen, N. D. , Stepanov, A. V. , Wu, N. C. , … Xie, J. (2018). Fully human agonist antibodies to TrkB using autocrine cell‐based selection from a combinatorial antibody library. Proceedings of the National Academy of Sciences of the United States of America, 115, E7023–E7032.29987039)
Merkouris, S. , Barde, Y. , Binley, K. E. , Allen, N. D. , Stepanov, A. V. , Wu, N. C. , … Xie, J. (2018). Fully human agonist antibodies to TrkB using autocrine cell‐based selection from a combinatorial antibody library. Proceedings of the National Academy of Sciences of the United States of America, 115, E7023–E7032.29987039
Merkouris, S. , Barde, Y. , Binley, K. E. , Allen, N. D. , Stepanov, A. V. , Wu, N. C. , … Xie, J. (2018). Fully human agonist antibodies to TrkB using autocrine cell‐based selection from a combinatorial antibody library. Proceedings of the National Academy of Sciences of the United States of America, 115, E7023–E7032.29987039, Merkouris, S. , Barde, Y. , Binley, K. E. , Allen, N. D. , Stepanov, A. V. , Wu, N. C. , … Xie, J. (2018). Fully human agonist antibodies to TrkB using autocrine cell‐based selection from a combinatorial antibody library. Proceedings of the National Academy of Sciences of the United States of America, 115, E7023–E7032.29987039
D. Goff, L. Leahy, I. Berman, T. Posever, L. Herz, A. Leon, Steven Johnson, G. Lynch (2001)
A Placebo-Controlled Pilot Study of the Ampakine CX516 Added to Clozapine in Schizophrenia
Journal of Clinical Psychopharmacology, 21
( Corbett, R. , Fielding, S. , Cornfeldt, M. , & Dunn, R. W. (1991). GABA mimetic agents display anxiolytic‐like effects in the social interaction and elevated plus maze procedures. Psychopharmacology, 104, 312–316.1681557)
Corbett, R. , Fielding, S. , Cornfeldt, M. , & Dunn, R. W. (1991). GABA mimetic agents display anxiolytic‐like effects in the social interaction and elevated plus maze procedures. Psychopharmacology, 104, 312–316.1681557
Corbett, R. , Fielding, S. , Cornfeldt, M. , & Dunn, R. W. (1991). GABA mimetic agents display anxiolytic‐like effects in the social interaction and elevated plus maze procedures. Psychopharmacology, 104, 312–316.1681557, Corbett, R. , Fielding, S. , Cornfeldt, M. , & Dunn, R. W. (1991). GABA mimetic agents display anxiolytic‐like effects in the social interaction and elevated plus maze procedures. Psychopharmacology, 104, 312–316.1681557
( Jones‐Davis, D. M. , Yang, M. , Rider, E. , Osbun, N. C. , da Gente, G. J. , Li, J. , … Sherr, E. H. (2013). Quantitative trait loci for interhemispheric commissure development and social behaviors in the BTBR T+ tf/J mouse model of autism. PLoS One, 8, e61829.23613947)
Jones‐Davis, D. M. , Yang, M. , Rider, E. , Osbun, N. C. , da Gente, G. J. , Li, J. , … Sherr, E. H. (2013). Quantitative trait loci for interhemispheric commissure development and social behaviors in the BTBR T+ tf/J mouse model of autism. PLoS One, 8, e61829.23613947
Jones‐Davis, D. M. , Yang, M. , Rider, E. , Osbun, N. C. , da Gente, G. J. , Li, J. , … Sherr, E. H. (2013). Quantitative trait loci for interhemispheric commissure development and social behaviors in the BTBR T+ tf/J mouse model of autism. PLoS One, 8, e61829.23613947, Jones‐Davis, D. M. , Yang, M. , Rider, E. , Osbun, N. C. , da Gente, G. J. , Li, J. , … Sherr, E. H. (2013). Quantitative trait loci for interhemispheric commissure development and social behaviors in the BTBR T+ tf/J mouse model of autism. PLoS One, 8, e61829.23613947
M. Cambiaghi, M. Cursi, L. Magri, V. Castoldi, G. Comi, F. Minicucci, R. Galli, L. Leocani (2013)
Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of Tuberous Sclerosis Complex
Neuropharmacology, 67
S. Massa, Tao Yang, Youmei Xie, Jian Shi, M. Bilgen, J. Joyce, Dean Nehama, Jayakumar Rajadas, F. Longo (2010)
Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents.
The Journal of clinical investigation, 120 5
E. Berry-Kravis, S. Krause, S. Block, Stephen Guter, J. Wuu, S. Leurgans, Pénélope Dècle, K. Potanos, E. Cook, Jeff Salt, D. Maino, D. Weinberg, Rebecca Lara, Tristan Jardini, J. Cogswell, Steven Johnson, R. Hagerman (2006)
Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial.
Journal of child and adolescent psychopharmacology, 16 5
( Bales, K. L. , Solomon, M. , Jacob, S. , Crawley, J. N. , Silverman, J. L. , Larke, R. H. , … Mendoza, S. P. (2014). Long‐term exposure to intranasal oxytocin in a mouse autism model. Translational Psychiatry, 4, e480.25386957)
Bales, K. L. , Solomon, M. , Jacob, S. , Crawley, J. N. , Silverman, J. L. , Larke, R. H. , … Mendoza, S. P. (2014). Long‐term exposure to intranasal oxytocin in a mouse autism model. Translational Psychiatry, 4, e480.25386957
Bales, K. L. , Solomon, M. , Jacob, S. , Crawley, J. N. , Silverman, J. L. , Larke, R. H. , … Mendoza, S. P. (2014). Long‐term exposure to intranasal oxytocin in a mouse autism model. Translational Psychiatry, 4, e480.25386957, Bales, K. L. , Solomon, M. , Jacob, S. , Crawley, J. N. , Silverman, J. L. , Larke, R. H. , … Mendoza, S. P. (2014). Long‐term exposure to intranasal oxytocin in a mouse autism model. Translational Psychiatry, 4, e480.25386957
( Rogers, S. J. , Vismara, L. , Wagner, A. L. , McCormick, C. , Young, G. , & Ozonoff, S. (2014). Autism treatment in the first year of life: A pilot study of infant start, a parent‐implemented intervention for symptomatic infants. Journal of Autism and Developmental Disorders, 44, 2981–2995.25212413)
Rogers, S. J. , Vismara, L. , Wagner, A. L. , McCormick, C. , Young, G. , & Ozonoff, S. (2014). Autism treatment in the first year of life: A pilot study of infant start, a parent‐implemented intervention for symptomatic infants. Journal of Autism and Developmental Disorders, 44, 2981–2995.25212413
Rogers, S. J. , Vismara, L. , Wagner, A. L. , McCormick, C. , Young, G. , & Ozonoff, S. (2014). Autism treatment in the first year of life: A pilot study of infant start, a parent‐implemented intervention for symptomatic infants. Journal of Autism and Developmental Disorders, 44, 2981–2995.25212413, Rogers, S. J. , Vismara, L. , Wagner, A. L. , McCormick, C. , Young, G. , & Ozonoff, S. (2014). Autism treatment in the first year of life: A pilot study of infant start, a parent‐implemented intervention for symptomatic infants. Journal of Autism and Developmental Disorders, 44, 2981–2995.25212413
( Cambiaghi, M. , Cursi, M. , Magri, L. , Castoldi, V. , Comi, G. , Minicucci, F. , … Leocani, L. (2013). Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex. Neuropharmacology, 67(1–7).)
Cambiaghi, M. , Cursi, M. , Magri, L. , Castoldi, V. , Comi, G. , Minicucci, F. , … Leocani, L. (2013). Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex. Neuropharmacology, 67(1–7).
Cambiaghi, M. , Cursi, M. , Magri, L. , Castoldi, V. , Comi, G. , Minicucci, F. , … Leocani, L. (2013). Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex. Neuropharmacology, 67(1–7)., Cambiaghi, M. , Cursi, M. , Magri, L. , Castoldi, V. , Comi, G. , Minicucci, F. , … Leocani, L. (2013). Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex. Neuropharmacology, 67(1–7).
( Lanthorn, T. (1994). D‐cycloserine: Agonist turned antagonist. Amino Acids, 6, 247–260.24189733)
Lanthorn, T. (1994). D‐cycloserine: Agonist turned antagonist. Amino Acids, 6, 247–260.24189733
Lanthorn, T. (1994). D‐cycloserine: Agonist turned antagonist. Amino Acids, 6, 247–260.24189733, Lanthorn, T. (1994). D‐cycloserine: Agonist turned antagonist. Amino Acids, 6, 247–260.24189733
( Carver, C. M. , & Reddy, D. S. (2013). Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: Regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology, 230, 151–188.24071826)
Carver, C. M. , & Reddy, D. S. (2013). Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: Regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology, 230, 151–188.24071826
Carver, C. M. , & Reddy, D. S. (2013). Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: Regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology, 230, 151–188.24071826, Carver, C. M. , & Reddy, D. S. (2013). Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: Regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology, 230, 151–188.24071826
P. Leach, Jacqueline Crawley (2018)
Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities
Genes, 17
I. Iossifov, B. O’Roak, Stephan Sanders, M. Ronemus, Niklas Krumm, D. Levy, H. Stessman, Kali Witherspoon, Laura Vives, K. Patterson, Joshua Smith, B. Paeper, D. Nickerson, Jeanselle Dea, Shan Dong, Luis Gonzalez, Jeffrey Mandell, S. Mane, M. Murtha, C. Sullivan, Michael Walker, Zainulabedin Waqar, Liping Wei, A. Willsey, B. Yamrom, Yoon-ha Lee, E. Grabowska, Ertugrul Dalkic, Zi-Hua Wang, S. Marks, P. Andrews, A. Leotta, J. Kendall, I. Hakker, J. Rosenbaum, Beicong Ma, L. Rodgers, J. Troge, G. Narzisi, Seungtai Yoon, M. Schatz, Kenny Ye, W. McCombie, J. Shendure, E. Eichler, M. State, M. Wigler (2014)
The contribution of de novo coding mutations to autism spectrum disorder
Nature, 515
( Berton, O. , McClung, C. A. , Dileone, R. J. , Krishna, V. , Renthal, W. , Russo, S. J. , … Nestler, E. J. (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science, 311, 864–868.16469931)
Berton, O. , McClung, C. A. , Dileone, R. J. , Krishna, V. , Renthal, W. , Russo, S. J. , … Nestler, E. J. (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science, 311, 864–868.16469931
Berton, O. , McClung, C. A. , Dileone, R. J. , Krishna, V. , Renthal, W. , Russo, S. J. , … Nestler, E. J. (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science, 311, 864–868.16469931, Berton, O. , McClung, C. A. , Dileone, R. J. , Krishna, V. , Renthal, W. , Russo, S. J. , … Nestler, E. J. (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science, 311, 864–868.16469931
( Baudouin, S. J. , Gaudias, J. , Gerharz, S. , Hatstatt, L. , Zhou, K. , Punnakkal, P. , … Scheiffele, P. (2012). Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science, 338, 128–132.22983708)
Baudouin, S. J. , Gaudias, J. , Gerharz, S. , Hatstatt, L. , Zhou, K. , Punnakkal, P. , … Scheiffele, P. (2012). Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science, 338, 128–132.22983708
Baudouin, S. J. , Gaudias, J. , Gerharz, S. , Hatstatt, L. , Zhou, K. , Punnakkal, P. , … Scheiffele, P. (2012). Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science, 338, 128–132.22983708, Baudouin, S. J. , Gaudias, J. , Gerharz, S. , Hatstatt, L. , Zhou, K. , Punnakkal, P. , … Scheiffele, P. (2012). Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science, 338, 128–132.22983708
Thomas Jaramillo, Haley Speed, Zhong Xuan, Jeremy Reimers, Shunan Liu, C. Powell (2016)
Altered Striatal Synaptic Function and Abnormal Behaviour in Shank3 Exon4‐9 Deletion Mouse Model of Autism
Autism Research, 9
Jessica Burket, A. Benson, Amy Tang, S. Deutsch (2014)
Rapamycin improves sociability in the BTBR T + Itpr3 tf /J mouse model of autism spectrum disorders
Brain Research Bulletin, 100
Andrew Chang, Victoria Berges, Sunho Chung, G. Fridman, J. Baraban, I. Reti (2015)
Methylphenidate modifies the motion of the circadian clock Lamotrigine in mood disorders and cocaine dependence Cortical glutamate in postpartum depression High Frequency Stimulation at the Subthalamic Nucleus Suppresses Excessive Self-Grooming in Autism-Like Mouse Models
J. Veenstra-VanderWeele, E. Cook, B. King, P. Zarevics, Maryann Cherubini, K. Walton-Bowen, M. Bear, Paul Wang, Randall Carpenter (2017)
Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial
Neuropsychopharmacology, 42
T. Kazdoba, R. Hagerman, D. Żółkowska, M. Rogawski, J. Crawley (2015)
Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism
Psychopharmacology, 233
( Lord, C. , & Jones, R. M. (2013). New strategies and findings for behavioral interventions in autism spectrum disorders. Annals of the New York Academy of Sciences, 1304, 70–76.24279894)
Lord, C. , & Jones, R. M. (2013). New strategies and findings for behavioral interventions in autism spectrum disorders. Annals of the New York Academy of Sciences, 1304, 70–76.24279894
Lord, C. , & Jones, R. M. (2013). New strategies and findings for behavioral interventions in autism spectrum disorders. Annals of the New York Academy of Sciences, 1304, 70–76.24279894, Lord, C. , & Jones, R. M. (2013). New strategies and findings for behavioral interventions in autism spectrum disorders. Annals of the New York Academy of Sciences, 1304, 70–76.24279894
A. Bartolomeis, G. Latte, C. Tomasetti, F. Iasevoli (2014)
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches
Molecular Neurobiology, 49
C. Betancur, J. Buxbaum (2013)
SHANK3 haploinsufficiency: a “common” but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders
Molecular Autism, 4
Laura Stoppel, T. Kazdoba, M. Schaffler, A. Preza, A. Heynen, J. Crawley, M. Bear (2017)
R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice
Neuropsychopharmacology, 43
G. Lynch, L. Palmer, C. Gall (2011)
The likelihood of cognitive enhancement
Pharmacology Biochemistry and Behavior, 99
( Phillips, M. , & Pozzo‐Miller, L. (2015). Dendritic spine dysgenesis in autism related disorders. Neuroscience Letters, 601, 30–40.25578949)
Phillips, M. , & Pozzo‐Miller, L. (2015). Dendritic spine dysgenesis in autism related disorders. Neuroscience Letters, 601, 30–40.25578949
Phillips, M. , & Pozzo‐Miller, L. (2015). Dendritic spine dysgenesis in autism related disorders. Neuroscience Letters, 601, 30–40.25578949, Phillips, M. , & Pozzo‐Miller, L. (2015). Dendritic spine dysgenesis in autism related disorders. Neuroscience Letters, 601, 30–40.25578949
Xiaoming Wang, P. McCoy, R. Rodriguiz, Yanzhen Pan, H. Je, A. Roberts, C. Kim, Janet Berrios, Jennifer Colvin, D. Bousquet-Moore, I. Lorenzo, Gangyi Wu, R. Weinberg, M. Ehlers, B. Philpot, A. Beaudet, W. Wetsel, Yong-hui Jiang (2011)
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3.
Human molecular genetics, 20 15
( Gogolla, G. , Leblanc, J. J. , Quast, K. B. , Südhof, T. C. , Fagiolini, M. , & Hensch, T. K. (2009). Common circuit defect of excitatory‐inhibitory balance in mouse models of autism. Journal of Neurodevelopmental Disorders, 1, 172–181.20664807)
Gogolla, G. , Leblanc, J. J. , Quast, K. B. , Südhof, T. C. , Fagiolini, M. , & Hensch, T. K. (2009). Common circuit defect of excitatory‐inhibitory balance in mouse models of autism. Journal of Neurodevelopmental Disorders, 1, 172–181.20664807
Gogolla, G. , Leblanc, J. J. , Quast, K. B. , Südhof, T. C. , Fagiolini, M. , & Hensch, T. K. (2009). Common circuit defect of excitatory‐inhibitory balance in mouse models of autism. Journal of Neurodevelopmental Disorders, 1, 172–181.20664807, Gogolla, G. , Leblanc, J. J. , Quast, K. B. , Südhof, T. C. , Fagiolini, M. , & Hensch, T. K. (2009). Common circuit defect of excitatory‐inhibitory balance in mouse models of autism. Journal of Neurodevelopmental Disorders, 1, 172–181.20664807
Geraldine Elfline, E. Branda, M. Babich, R. Quock (2004)
Antagonism by NOS Inhibition of the Behavioral Effects of Benzodiazepine and GABAA Receptor Agonists in the Mouse Elevated Plus-Maze
Neuropsychopharmacology, 29
( Pearson, B. L. , Pobbe, R. L. , Defensor, E. B. , Oasay, L. , Bolivar, V. J. , Blancard, D. C. , & Blanchard, R. J. (2011). Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism. Genes, Brain, and Behavior, 10, 228–235.)
Pearson, B. L. , Pobbe, R. L. , Defensor, E. B. , Oasay, L. , Bolivar, V. J. , Blancard, D. C. , & Blanchard, R. J. (2011). Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism. Genes, Brain, and Behavior, 10, 228–235.
Pearson, B. L. , Pobbe, R. L. , Defensor, E. B. , Oasay, L. , Bolivar, V. J. , Blancard, D. C. , & Blanchard, R. J. (2011). Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism. Genes, Brain, and Behavior, 10, 228–235., Pearson, B. L. , Pobbe, R. L. , Defensor, E. B. , Oasay, L. , Bolivar, V. J. , Blancard, D. C. , & Blanchard, R. J. (2011). Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism. Genes, Brain, and Behavior, 10, 228–235.
Kati Saarelainen, Martin Ranna, H. Rabe, S. Sinkkonen, Tommi Möykkynen, M. Uusi-Oukari, A. Linden, H. Lüddens, E. Korpi (2008)
Enhanced behavioral sensitivity to the competitive GABA agonist, gaboxadol, in transgenic mice over‐expressing hippocampal extrasynaptic α6β GABAA receptors
Journal of Neurochemistry, 105
( Ramaker, M. J. , Ford, M. M. , Phillips, T. J. , & Finn, D. A. (2014). Differences in the reinstatement of ethanol seeking with ganaxolone and gaboxadol. Neuroscience, 272, 180–187.24814021)
Ramaker, M. J. , Ford, M. M. , Phillips, T. J. , & Finn, D. A. (2014). Differences in the reinstatement of ethanol seeking with ganaxolone and gaboxadol. Neuroscience, 272, 180–187.24814021
Ramaker, M. J. , Ford, M. M. , Phillips, T. J. , & Finn, D. A. (2014). Differences in the reinstatement of ethanol seeking with ganaxolone and gaboxadol. Neuroscience, 272, 180–187.24814021, Ramaker, M. J. , Ford, M. M. , Phillips, T. J. , & Finn, D. A. (2014). Differences in the reinstatement of ethanol seeking with ganaxolone and gaboxadol. Neuroscience, 272, 180–187.24814021
( Ogier, M. , Wang, H. , Hong, E. , Wang, Q. , Greenberg, M. E. , & Katz, D. M. (2007). Brain‐derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. The Journal of Neuroscience, 27, 10912–10917.17913925)
Ogier, M. , Wang, H. , Hong, E. , Wang, Q. , Greenberg, M. E. , & Katz, D. M. (2007). Brain‐derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. The Journal of Neuroscience, 27, 10912–10917.17913925
Ogier, M. , Wang, H. , Hong, E. , Wang, Q. , Greenberg, M. E. , & Katz, D. M. (2007). Brain‐derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. The Journal of Neuroscience, 27, 10912–10917.17913925, Ogier, M. , Wang, H. , Hong, E. , Wang, Q. , Greenberg, M. E. , & Katz, D. M. (2007). Brain‐derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. The Journal of Neuroscience, 27, 10912–10917.17913925
Y. Mei, P. Monteiro, Yang Zhou, Jinah Kim, Xian Gao, Z. Fu, G. Feng (2016)
Adult Restoration of Shank3 Expression Rescues Selective Autistic-Like Phenotypes
Nature, 530
( Wang, X. , McCoy, P. A. , Rodriguiz, R. M. , Pan, Y. , Je, H. S. , Roberts, A. C. , … Jiang, Y. H. (2011). Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3 . Human Molecular Genetics, 20, 3093–3108.21558424)
Wang, X. , McCoy, P. A. , Rodriguiz, R. M. , Pan, Y. , Je, H. S. , Roberts, A. C. , … Jiang, Y. H. (2011). Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3 . Human Molecular Genetics, 20, 3093–3108.21558424
Wang, X. , McCoy, P. A. , Rodriguiz, R. M. , Pan, Y. , Je, H. S. , Roberts, A. C. , … Jiang, Y. H. (2011). Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3 . Human Molecular Genetics, 20, 3093–3108.21558424, Wang, X. , McCoy, P. A. , Rodriguiz, R. M. , Pan, Y. , Je, H. S. , Roberts, A. C. , … Jiang, Y. H. (2011). Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3 . Human Molecular Genetics, 20, 3093–3108.21558424
H. Schoch, A. Kreibich, Sarah Ferri, R. White, Dominique Bohorquez, Anamika Banerjee, Russell Port, H. Dow, Lucero Cordero, Ashley Pallathra, Hyong Kim, Hongzhe Li, W. Bilker, S. Hirano, R. Schultz, K. Borgmann-Winter, C. Hahn, D. Feldmeyer, G. Carlson, T. Abel, E. Brodkin (2017)
Sociability Deficits and Altered Amygdala Circuits in Mice Lacking Pcdh10, an Autism Associated Gene
Biological Psychiatry, 81
M. Mitre, Abigail Mariga, M. Chao (2016)
Neurotrophin signalling: novel insights into mechanisms and pathophysiology.
Clinical science, 131 1
( Daimon, C. M. , Jasien, J. M. , Wood, W. H., 3rd , Zhang, Y. , Becker, K. G. , Silverman, J. L. , … Maudsley, S. (2015). Hippocampal transcriptomic and proteomic alterations in the BTBR mouse model of autism spectrum disorder. Frontiers in Physiology, 6, 324.26635614)
Daimon, C. M. , Jasien, J. M. , Wood, W. H., 3rd , Zhang, Y. , Becker, K. G. , Silverman, J. L. , … Maudsley, S. (2015). Hippocampal transcriptomic and proteomic alterations in the BTBR mouse model of autism spectrum disorder. Frontiers in Physiology, 6, 324.26635614
Daimon, C. M. , Jasien, J. M. , Wood, W. H., 3rd , Zhang, Y. , Becker, K. G. , Silverman, J. L. , … Maudsley, S. (2015). Hippocampal transcriptomic and proteomic alterations in the BTBR mouse model of autism spectrum disorder. Frontiers in Physiology, 6, 324.26635614, Daimon, C. M. , Jasien, J. M. , Wood, W. H., 3rd , Zhang, Y. , Becker, K. G. , Silverman, J. L. , … Maudsley, S. (2015). Hippocampal transcriptomic and proteomic alterations in the BTBR mouse model of autism spectrum disorder. Frontiers in Physiology, 6, 324.26635614
( Iossifov, I. , O'Roak, B. J. , Sanders, S. J. , Ronemus, M., Krumm, N., Levy, D., … Wigler, M. (2014). The contribution of de novo coding mutations to autism spectrum disorder. Nature, 515, 216–221.25363768)
Iossifov, I. , O'Roak, B. J. , Sanders, S. J. , Ronemus, M., Krumm, N., Levy, D., … Wigler, M. (2014). The contribution of de novo coding mutations to autism spectrum disorder. Nature, 515, 216–221.25363768
Iossifov, I. , O'Roak, B. J. , Sanders, S. J. , Ronemus, M., Krumm, N., Levy, D., … Wigler, M. (2014). The contribution of de novo coding mutations to autism spectrum disorder. Nature, 515, 216–221.25363768, Iossifov, I. , O'Roak, B. J. , Sanders, S. J. , Ronemus, M., Krumm, N., Levy, D., … Wigler, M. (2014). The contribution of de novo coding mutations to autism spectrum disorder. Nature, 515, 216–221.25363768
R. Corbett, S. Fielding, M. Cornfeldt, R. Dunn (2005)
GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures
Psychopharmacology, 104
Peter Tsai, Court Hull, Y. Chu, E. Greene-Colozzi, Abbey Sadowski, J. Leech, Jason Steinberg, J. Crawley, W. Regehr, M. Sahin (2012)
Autistic-like behavior and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice
Nature, 488
Helen Bateup, Caroline Johnson, Cassandra Denefrio, Jessica Saulnier, K. Kornacker, B. Sabatini (2013)
Excitatory/Inhibitory Synaptic Imbalance Leads to Hippocampal Hyperexcitability in Mouse Models of Tuberous Sclerosis
Neuron, 78
Zuleyha Cidav, J. Munson, A. Estes, G. Dawson, S. Rogers, D. Mandell (2017)
Cost Offset Associated With Early Start Denver Model for Children With Autism.
Journal of the American Academy of Child and Adolescent Psychiatry, 56 9
( Baxter, M. G. , Lanthorn, T. H. , Frick, K. M. , Golski, S. , Wan, R. Q. , & Olton, D. S. (1994). D‐cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats. Neurobiology of Aging, 15, 207–213.7838293)
Baxter, M. G. , Lanthorn, T. H. , Frick, K. M. , Golski, S. , Wan, R. Q. , & Olton, D. S. (1994). D‐cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats. Neurobiology of Aging, 15, 207–213.7838293
Baxter, M. G. , Lanthorn, T. H. , Frick, K. M. , Golski, S. , Wan, R. Q. , & Olton, D. S. (1994). D‐cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats. Neurobiology of Aging, 15, 207–213.7838293, Baxter, M. G. , Lanthorn, T. H. , Frick, K. M. , Golski, S. , Wan, R. Q. , & Olton, D. S. (1994). D‐cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats. Neurobiology of Aging, 15, 207–213.7838293
( Lovinger, D. M. (2017). An indirect route to repetitive actions. The Journal of Clinical Investigation, 127, 1618–1621.28414299)
Lovinger, D. M. (2017). An indirect route to repetitive actions. The Journal of Clinical Investigation, 127, 1618–1621.28414299
Lovinger, D. M. (2017). An indirect route to repetitive actions. The Journal of Clinical Investigation, 127, 1618–1621.28414299, Lovinger, D. M. (2017). An indirect route to repetitive actions. The Journal of Clinical Investigation, 127, 1618–1621.28414299
C. Durand, C. Betancur, Tobias Boeckers, Juergen Bockmann, P. Chaste, F. Fauchereau, G. Nygren, M. Råstam, I. Gillberg, H. Anckarsäter, E. Sponheim, Hany Goubran‐Botros, R. Delorme, N. Chabane, M. Mouren-Siméoni, P. Mas, E. Bieth, B. Rogé, D. Heron, L. Burglen, C. Gillberg, M. Leboyer, T. Bourgeron (2007)
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Nature Genetics, 39
( Brown, N. , Kerby, J. , Bonnert, T. P. , Whiting, P. J. , & Wafford, K. A. (2002). Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. British Journal of Pharmacology, 136, 965–974.12145096)
Brown, N. , Kerby, J. , Bonnert, T. P. , Whiting, P. J. , & Wafford, K. A. (2002). Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. British Journal of Pharmacology, 136, 965–974.12145096
Brown, N. , Kerby, J. , Bonnert, T. P. , Whiting, P. J. , & Wafford, K. A. (2002). Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. British Journal of Pharmacology, 136, 965–974.12145096, Brown, N. , Kerby, J. , Bonnert, T. P. , Whiting, P. J. , & Wafford, K. A. (2002). Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. British Journal of Pharmacology, 136, 965–974.12145096
( Seese, R. R. , Maske, A. R. , Lynch, G. , & Gall, C. M. (2014). Long‐term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism. Neuropsychopharmacology, 39, 1664–1673.24448645)
Seese, R. R. , Maske, A. R. , Lynch, G. , & Gall, C. M. (2014). Long‐term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism. Neuropsychopharmacology, 39, 1664–1673.24448645
Seese, R. R. , Maske, A. R. , Lynch, G. , & Gall, C. M. (2014). Long‐term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism. Neuropsychopharmacology, 39, 1664–1673.24448645, Seese, R. R. , Maske, A. R. , Lynch, G. , & Gall, C. M. (2014). Long‐term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism. Neuropsychopharmacology, 39, 1664–1673.24448645
( Brielmaier, J. , Senerth, J. M. , Silverman, J. L. , Matteson, P. G. , Millonig, J. H. , Dicicco‐Bloom, E. , & Crawley, J. N. (2014). Chronic desipramine treatment rescues depression‐related, social and cognitive deficits in Engrailed‐2 knockout mice. Genes, Brain, and Behavior, 13, 286–298.)
Brielmaier, J. , Senerth, J. M. , Silverman, J. L. , Matteson, P. G. , Millonig, J. H. , Dicicco‐Bloom, E. , & Crawley, J. N. (2014). Chronic desipramine treatment rescues depression‐related, social and cognitive deficits in Engrailed‐2 knockout mice. Genes, Brain, and Behavior, 13, 286–298.
Brielmaier, J. , Senerth, J. M. , Silverman, J. L. , Matteson, P. G. , Millonig, J. H. , Dicicco‐Bloom, E. , & Crawley, J. N. (2014). Chronic desipramine treatment rescues depression‐related, social and cognitive deficits in Engrailed‐2 knockout mice. Genes, Brain, and Behavior, 13, 286–298., Brielmaier, J. , Senerth, J. M. , Silverman, J. L. , Matteson, P. G. , Millonig, J. H. , Dicicco‐Bloom, E. , & Crawley, J. N. (2014). Chronic desipramine treatment rescues depression‐related, social and cognitive deficits in Engrailed‐2 knockout mice. Genes, Brain, and Behavior, 13, 286–298.
Ryan Yuen, D. Merico, M. Bookman, Jennifer Howe, B. Thiruvahindrapuram, R. Patel, J. Whitney, N. Deflaux, J. Bingham, Zhuozhi Wang, G. Pellecchia, J. Buchanan, S. Walker, C. Marshall, M. Uddin, M. Zarrei, E. Deneault, L. D’Abate, A. Chan, S. Koyanagi, T. Paton, S. Pereira, N. Hoang, W. Engchuan, E. Higginbotham, Karen Ho, S. Lamoureux, Weili Li, J. MacDonald, T. Nalpathamkalam, W. Sung, Fiona Tsoi, John Wei, Lizhen Xu, A. Tassé, Emily Kirby, W. Etten, S. Twigger, W. Roberts, Irene Drmic, Sanne Jilderda, B. Modi, B. Kellam, M. Szego, C. Cytrynbaum, R. Weksberg, L. Zwaigenbaum, M. Woodbury-Smith, J. Brian, Lili Senman, A. Iaboni, K. Doyle‐Thomas, A. Thompson, Christina Chrysler, J. Leef, T. Savion-Lemieux, I. Smith, Xudong Liu, R. Nicolson, V. Seifer, A. Fedele, E. Cook, S. Dager, A. Estes, L. Gallagher, B. Malow, J. Parr, S. Spence, J. Vorstman, B. Frey, James Robinson, L. Strug, B. Fernandez, M. Elsabbagh, M. Carter, Joachim Hallmayer, B. Knoppers, E. Anagnostou, P. Szatmari, R. Ring, David Glazer, M. Pletcher, S. Scherer (2017)
Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
Nature Neuroscience, 20
( Durand, C. M. , Betancur, C. , Boeckers, T. M. , Bockmann, J. , Chaste, P. , Fauchereau, F. , … Bourgeron, T. (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics, 39, 25–27.17173049)
Durand, C. M. , Betancur, C. , Boeckers, T. M. , Bockmann, J. , Chaste, P. , Fauchereau, F. , … Bourgeron, T. (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics, 39, 25–27.17173049
Durand, C. M. , Betancur, C. , Boeckers, T. M. , Bockmann, J. , Chaste, P. , Fauchereau, F. , … Bourgeron, T. (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics, 39, 25–27.17173049, Durand, C. M. , Betancur, C. , Boeckers, T. M. , Bockmann, J. , Chaste, P. , Fauchereau, F. , … Bourgeron, T. (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics, 39, 25–27.17173049
Yang Zhou, Tobias Kaiser, P. Monteiro, Xiangyu Zhang, M. Goes, Dongqing Wang, B. Barak, Menglong Zeng, Chen-chen Li, Congyi Lu, Michael Wells, A. Amaya, Shannon Nguyen, Michael Lewis, Neville Sanjana, Yong Zhou, Mingjie Zhang, Feng Zhang, Z. Fu, G. Feng (2016)
Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects
Neuron, 89
( Meera, P. , Wallner, M. , & Otis, T. S. (2011). Molecular basis for the high THIP/gaboxadol sensitivity of extrasynaptic GABA‐A receptors. Journal of Neurophysiology, 106, 2057–2064.21795619)
Meera, P. , Wallner, M. , & Otis, T. S. (2011). Molecular basis for the high THIP/gaboxadol sensitivity of extrasynaptic GABA‐A receptors. Journal of Neurophysiology, 106, 2057–2064.21795619
Meera, P. , Wallner, M. , & Otis, T. S. (2011). Molecular basis for the high THIP/gaboxadol sensitivity of extrasynaptic GABA‐A receptors. Journal of Neurophysiology, 106, 2057–2064.21795619, Meera, P. , Wallner, M. , & Otis, T. S. (2011). Molecular basis for the high THIP/gaboxadol sensitivity of extrasynaptic GABA‐A receptors. Journal of Neurophysiology, 106, 2057–2064.21795619
( Myers, K. M. , & Carlezon, W. A. (2012). D‐cycloserine effects on extinction of conditioned responses to drug‐related cues. Biological Psychiatry, 71, 947–955.22579305)
Myers, K. M. , & Carlezon, W. A. (2012). D‐cycloserine effects on extinction of conditioned responses to drug‐related cues. Biological Psychiatry, 71, 947–955.22579305
Myers, K. M. , & Carlezon, W. A. (2012). D‐cycloserine effects on extinction of conditioned responses to drug‐related cues. Biological Psychiatry, 71, 947–955.22579305, Myers, K. M. , & Carlezon, W. A. (2012). D‐cycloserine effects on extinction of conditioned responses to drug‐related cues. Biological Psychiatry, 71, 947–955.22579305
( Berry‐Kravis, E. , Krause, S. E. , Block, S. S. , Guter, S. , Wuu, J. , Leurgans, S. , … Hagerman, R. (2006). Effect of CX516, an AMPA‐modulating compound, on cognition and behavior in fragile X syndrome: A controlled trial. Journal of Child and Adolescent Psychopharmacology, 16, 525–540.17069542)
Berry‐Kravis, E. , Krause, S. E. , Block, S. S. , Guter, S. , Wuu, J. , Leurgans, S. , … Hagerman, R. (2006). Effect of CX516, an AMPA‐modulating compound, on cognition and behavior in fragile X syndrome: A controlled trial. Journal of Child and Adolescent Psychopharmacology, 16, 525–540.17069542
Berry‐Kravis, E. , Krause, S. E. , Block, S. S. , Guter, S. , Wuu, J. , Leurgans, S. , … Hagerman, R. (2006). Effect of CX516, an AMPA‐modulating compound, on cognition and behavior in fragile X syndrome: A controlled trial. Journal of Child and Adolescent Psychopharmacology, 16, 525–540.17069542, Berry‐Kravis, E. , Krause, S. E. , Block, S. S. , Guter, S. , Wuu, J. , Leurgans, S. , … Hagerman, R. (2006). Effect of CX516, an AMPA‐modulating compound, on cognition and behavior in fragile X syndrome: A controlled trial. Journal of Child and Adolescent Psychopharmacology, 16, 525–540.17069542
( Cidav, Z. , Munson, J. , Estes, A. , Dawson, G. , Rogers, S. , & Mandell, D. (2017). Cost offset associated with early start Denver model for children with autism. Journal of the American Academy of Child and Adolescent Psychiatry, 56, 777–783.28838582)
Cidav, Z. , Munson, J. , Estes, A. , Dawson, G. , Rogers, S. , & Mandell, D. (2017). Cost offset associated with early start Denver model for children with autism. Journal of the American Academy of Child and Adolescent Psychiatry, 56, 777–783.28838582
Cidav, Z. , Munson, J. , Estes, A. , Dawson, G. , Rogers, S. , & Mandell, D. (2017). Cost offset associated with early start Denver model for children with autism. Journal of the American Academy of Child and Adolescent Psychiatry, 56, 777–783.28838582, Cidav, Z. , Munson, J. , Estes, A. , Dawson, G. , Rogers, S. , & Mandell, D. (2017). Cost offset associated with early start Denver model for children with autism. Journal of the American Academy of Child and Adolescent Psychiatry, 56, 777–783.28838582
( Bozdagi, O. , Sakurai, T. , Papapetrou, D. , Wang, X. , Dickstein, D. L. , Takahashi, N. , … Buxbaum, J. D. (2010). Haploinsufficiency of the autism‐associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism., 1, 15.21167025)
Bozdagi, O. , Sakurai, T. , Papapetrou, D. , Wang, X. , Dickstein, D. L. , Takahashi, N. , … Buxbaum, J. D. (2010). Haploinsufficiency of the autism‐associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism., 1, 15.21167025
Bozdagi, O. , Sakurai, T. , Papapetrou, D. , Wang, X. , Dickstein, D. L. , Takahashi, N. , … Buxbaum, J. D. (2010). Haploinsufficiency of the autism‐associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism., 1, 15.21167025, Bozdagi, O. , Sakurai, T. , Papapetrou, D. , Wang, X. , Dickstein, D. L. , Takahashi, N. , … Buxbaum, J. D. (2010). Haploinsufficiency of the autism‐associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism., 1, 15.21167025
( Devi, L. , & Ohno, M. (2011). 7,8‐dihydroxyflavone, a small‐molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology, 37, 434–444.21900882)
Devi, L. , & Ohno, M. (2011). 7,8‐dihydroxyflavone, a small‐molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology, 37, 434–444.21900882
Devi, L. , & Ohno, M. (2011). 7,8‐dihydroxyflavone, a small‐molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology, 37, 434–444.21900882, Devi, L. , & Ohno, M. (2011). 7,8‐dihydroxyflavone, a small‐molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology, 37, 434–444.21900882
Jennifer Brielmaier, Jennifer Brielmaier, Julia Senerth, J. Silverman, P. Matteson, J. Millonig, E. Dicicco-Bloom, J. Crawley (2014)
Chronic desipramine treatment rescues depression‐related, social and cognitive deficits in Engrailed‐2 knockout mice
Genes, 13
Jill Silverman, Mu Yang, Sarah Turner, Adam Katz, Dana Bell, James Koenig, Jacqueline Crawley (2010)
Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism
Neuroscience, 171
( Stephenson, D. T. , O'Neill, S. M. , Narayan, S. , Tiwari, A. , Arnold, E. , Samaroo, H. D. , … Morton, D. (2011). Histopathologic characterization of the BTBR mouse model of autistic‐like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Molecular Autism, 2, 7.21575186)
Stephenson, D. T. , O'Neill, S. M. , Narayan, S. , Tiwari, A. , Arnold, E. , Samaroo, H. D. , … Morton, D. (2011). Histopathologic characterization of the BTBR mouse model of autistic‐like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Molecular Autism, 2, 7.21575186
Stephenson, D. T. , O'Neill, S. M. , Narayan, S. , Tiwari, A. , Arnold, E. , Samaroo, H. D. , … Morton, D. (2011). Histopathologic characterization of the BTBR mouse model of autistic‐like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Molecular Autism, 2, 7.21575186, Stephenson, D. T. , O'Neill, S. M. , Narayan, S. , Tiwari, A. , Arnold, E. , Samaroo, H. D. , … Morton, D. (2011). Histopathologic characterization of the BTBR mouse model of autistic‐like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Molecular Autism, 2, 7.21575186
R. Yoshimura, M. Tran, D. Hogenkamp, Narielle Ayala, T. Johnstone, Andrew Dunnigan, Timothy Gee, K. Gee (2017)
Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism-like behaviors in the BTBR mouse model
Neuropharmacology, 126
( Gould, G. G. , Seillier, A. , Weiss, G. , Giuffrida, A. , Burke, T. F. , Hensler, J. G. , … Schultz, S. T. (2012). Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. Progress in Neuro‐Psychopharmacology & Biological Psychiatry, 38, 260–269.22542870)
Gould, G. G. , Seillier, A. , Weiss, G. , Giuffrida, A. , Burke, T. F. , Hensler, J. G. , … Schultz, S. T. (2012). Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. Progress in Neuro‐Psychopharmacology & Biological Psychiatry, 38, 260–269.22542870
Gould, G. G. , Seillier, A. , Weiss, G. , Giuffrida, A. , Burke, T. F. , Hensler, J. G. , … Schultz, S. T. (2012). Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. Progress in Neuro‐Psychopharmacology & Biological Psychiatry, 38, 260–269.22542870, Gould, G. G. , Seillier, A. , Weiss, G. , Giuffrida, A. , Burke, T. F. , Hensler, J. G. , … Schultz, S. T. (2012). Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. Progress in Neuro‐Psychopharmacology & Biological Psychiatry, 38, 260–269.22542870
( Benson, A. D. , Burket, A. D. , & Deutsch, S. I. (2013). Balb/c mice treated with D‐cycloserine arouse increased social interest in conspecifics. Brain Research Bulletin, 99, 95–99.24157954)
Benson, A. D. , Burket, A. D. , & Deutsch, S. I. (2013). Balb/c mice treated with D‐cycloserine arouse increased social interest in conspecifics. Brain Research Bulletin, 99, 95–99.24157954
Benson, A. D. , Burket, A. D. , & Deutsch, S. I. (2013). Balb/c mice treated with D‐cycloserine arouse increased social interest in conspecifics. Brain Research Bulletin, 99, 95–99.24157954, Benson, A. D. , Burket, A. D. , & Deutsch, S. I. (2013). Balb/c mice treated with D‐cycloserine arouse increased social interest in conspecifics. Brain Research Bulletin, 99, 95–99.24157954
( Henry, F. E. , Hockeimer, W. , Chen, A. , Mysore, S. P. , & Sutton, M. A. (2017). Mechanistic target of rapamycin is necessary for changes in dendritic spine morphology associated with long‐term potentiation. Molecular Brain, 10, 50.29084578)
Henry, F. E. , Hockeimer, W. , Chen, A. , Mysore, S. P. , & Sutton, M. A. (2017). Mechanistic target of rapamycin is necessary for changes in dendritic spine morphology associated with long‐term potentiation. Molecular Brain, 10, 50.29084578
Henry, F. E. , Hockeimer, W. , Chen, A. , Mysore, S. P. , & Sutton, M. A. (2017). Mechanistic target of rapamycin is necessary for changes in dendritic spine morphology associated with long‐term potentiation. Molecular Brain, 10, 50.29084578, Henry, F. E. , Hockeimer, W. , Chen, A. , Mysore, S. P. , & Sutton, M. A. (2017). Mechanistic target of rapamycin is necessary for changes in dendritic spine morphology associated with long‐term potentiation. Molecular Brain, 10, 50.29084578
M. Peixoto, N. Araujo, R. Silva, J. Castro, D. Fukushiro, R. Faria, P. Zanier-Gomes, W. Medrano, R. Frussa‐Filho, V. Abílio (2005)
Effects of gabaergic drugs on reserpine-induced oral dyskinesia
Behavioural Brain Research, 160
C. Erickson, Logan Wink, Maureen Early, Elizabeth Stiegelmeyer, Lauren Mathieu-Frasier, Vanessa Patrick, C. McDougle (2014)
Brief Report: Pilot Single-Blind Placebo Lead-In Study of Acamprosate in Youth with Autistic Disorder
Journal of Autism and Developmental Disorders, 44
( Davis, M. , Ressler, K. , Rothbaum, B. O. , & Richardson, R. (2006). Effects of D‐cycloserine on extinction: Translation from preclinical to clinical work. Biological Psychiatry, 60, 369–375.16919524)
Davis, M. , Ressler, K. , Rothbaum, B. O. , & Richardson, R. (2006). Effects of D‐cycloserine on extinction: Translation from preclinical to clinical work. Biological Psychiatry, 60, 369–375.16919524
Davis, M. , Ressler, K. , Rothbaum, B. O. , & Richardson, R. (2006). Effects of D‐cycloserine on extinction: Translation from preclinical to clinical work. Biological Psychiatry, 60, 369–375.16919524, Davis, M. , Ressler, K. , Rothbaum, B. O. , & Richardson, R. (2006). Effects of D‐cycloserine on extinction: Translation from preclinical to clinical work. Biological Psychiatry, 60, 369–375.16919524
Nadine Gogolla, J. LeBlanc, K. Quast, T. Südhof, M. Fagiolini, T. Hensch (2009)
Common circuit defect of excitatory-inhibitory balance in mouse models of autism
Journal of neurodevelopmental disorders, 1
( Bove, M. , Ike, K. , Eldering, A. , Buwalda, B. , de Boer, S. F. , Morgese, M. G. , … Kas, M. J. H. (2018). The visible burrow system: A behavioral paradigm to assess sociability and social withdrawal in BTBR and C57BL/6J mice strains. Behavioural Brain Research, 15, 9–19.)
Bove, M. , Ike, K. , Eldering, A. , Buwalda, B. , de Boer, S. F. , Morgese, M. G. , … Kas, M. J. H. (2018). The visible burrow system: A behavioral paradigm to assess sociability and social withdrawal in BTBR and C57BL/6J mice strains. Behavioural Brain Research, 15, 9–19.
Bove, M. , Ike, K. , Eldering, A. , Buwalda, B. , de Boer, S. F. , Morgese, M. G. , … Kas, M. J. H. (2018). The visible burrow system: A behavioral paradigm to assess sociability and social withdrawal in BTBR and C57BL/6J mice strains. Behavioural Brain Research, 15, 9–19., Bove, M. , Ike, K. , Eldering, A. , Buwalda, B. , de Boer, S. F. , Morgese, M. G. , … Kas, M. J. H. (2018). The visible burrow system: A behavioral paradigm to assess sociability and social withdrawal in BTBR and C57BL/6J mice strains. Behavioural Brain Research, 15, 9–19.
( Mitre, M. , Mariga, A. , & Chao, M. V. (2017). Neurotrophin signalling: Novel insights into mechanisms and pathophysiology. Clinical Science (London, England), 131, 13–23.)
Mitre, M. , Mariga, A. , & Chao, M. V. (2017). Neurotrophin signalling: Novel insights into mechanisms and pathophysiology. Clinical Science (London, England), 131, 13–23.
Mitre, M. , Mariga, A. , & Chao, M. V. (2017). Neurotrophin signalling: Novel insights into mechanisms and pathophysiology. Clinical Science (London, England), 131, 13–23., Mitre, M. , Mariga, A. , & Chao, M. V. (2017). Neurotrophin signalling: Novel insights into mechanisms and pathophysiology. Clinical Science (London, England), 131, 13–23.
D. Lovinger (2017)
An indirect route to repetitive actions
, 127
Dorothy Jones‐Davis, Mu Yang, Eric Rider, Nathan Osbun, Gilberto Gente, Jiang-chao Li, Adam Katz, Michael Weber, Ś. Sen, J. Crawley, E. Sherr (2013)
Quantitative Trait Loci for Interhemispheric Commissure Development and Social Behaviors in the BTBR T+ tf/J Mouse Model of Autism
PLoS ONE, 8
B. Pearson, Jaclyn Bettis, Ksenia Meyza, Lace Yamamoto, D. Blanchard, R. Blanchard (2012)
Absence of social conditioned place preference in BTBR T+tf/J mice: Relevance for social motivation testing in rodent models of autism
Behavioural Brain Research, 233
( Defensor, E. B. , Pearson, B. L. , Pobbe, R. L. , Bolivar, V. J. , Blanchard, D. C. , & Blanchard, R. J. (2011). A novel social proximity test suggests patterns of social avoidance and gaze aversion‐like behavior in BTBR T+ tf/J mice. Behavioural Brain Research, 217, 302–308.21055421)
Defensor, E. B. , Pearson, B. L. , Pobbe, R. L. , Bolivar, V. J. , Blanchard, D. C. , & Blanchard, R. J. (2011). A novel social proximity test suggests patterns of social avoidance and gaze aversion‐like behavior in BTBR T+ tf/J mice. Behavioural Brain Research, 217, 302–308.21055421
Defensor, E. B. , Pearson, B. L. , Pobbe, R. L. , Bolivar, V. J. , Blanchard, D. C. , & Blanchard, R. J. (2011). A novel social proximity test suggests patterns of social avoidance and gaze aversion‐like behavior in BTBR T+ tf/J mice. Behavioural Brain Research, 217, 302–308.21055421, Defensor, E. B. , Pearson, B. L. , Pobbe, R. L. , Bolivar, V. J. , Blanchard, D. C. , & Blanchard, R. J. (2011). A novel social proximity test suggests patterns of social avoidance and gaze aversion‐like behavior in BTBR T+ tf/J mice. Behavioural Brain Research, 217, 302–308.21055421
M. Farrant, Z. Nusser (2005)
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Nature Reviews Neuroscience, 6
( Kazdoba, T. M. , Leach, P. T. , Yang, M. , Silverman, J. L. , Solomon, M. , & Crawley, J. N. (2016b). Translational mouse models of autism: Advancing toward pharmacological therapeutics. Current Topics in Behavioral Neurosciences, 28, 1–52.27305922)
Kazdoba, T. M. , Leach, P. T. , Yang, M. , Silverman, J. L. , Solomon, M. , & Crawley, J. N. (2016b). Translational mouse models of autism: Advancing toward pharmacological therapeutics. Current Topics in Behavioral Neurosciences, 28, 1–52.27305922
Kazdoba, T. M. , Leach, P. T. , Yang, M. , Silverman, J. L. , Solomon, M. , & Crawley, J. N. (2016b). Translational mouse models of autism: Advancing toward pharmacological therapeutics. Current Topics in Behavioral Neurosciences, 28, 1–52.27305922, Kazdoba, T. M. , Leach, P. T. , Yang, M. , Silverman, J. L. , Solomon, M. , & Crawley, J. N. (2016b). Translational mouse models of autism: Advancing toward pharmacological therapeutics. Current Topics in Behavioral Neurosciences, 28, 1–52.27305922
( Mohler, H. (2015). The legacy of the benzodiazepine receptor: From flumazenil to enhancing cognition in Down syndrome and social interaction in autism. Advances in Pharmacology, 72, 1–36.25600365)
Mohler, H. (2015). The legacy of the benzodiazepine receptor: From flumazenil to enhancing cognition in Down syndrome and social interaction in autism. Advances in Pharmacology, 72, 1–36.25600365
Mohler, H. (2015). The legacy of the benzodiazepine receptor: From flumazenil to enhancing cognition in Down syndrome and social interaction in autism. Advances in Pharmacology, 72, 1–36.25600365, Mohler, H. (2015). The legacy of the benzodiazepine receptor: From flumazenil to enhancing cognition in Down syndrome and social interaction in autism. Advances in Pharmacology, 72, 1–36.25600365
Andrew Hartzell, R. Paulus, J. Schulkin (1985)
Brief preoperative exposure to saline protects rats against behavioral impairments in salt appetite following central gustatory damage
Behavioural Brain Research, 15
( Yang, M. , Zhodzishsky, V. , & Crawley, J. N. (2007). Social deficits in BTBR T+tf/J mice are unchanged by cross‐fostering with C57BL/6J mothers. International Journal of Developmental Neuroscience, 25, 515–521.17980995)
Yang, M. , Zhodzishsky, V. , & Crawley, J. N. (2007). Social deficits in BTBR T+tf/J mice are unchanged by cross‐fostering with C57BL/6J mothers. International Journal of Developmental Neuroscience, 25, 515–521.17980995
Yang, M. , Zhodzishsky, V. , & Crawley, J. N. (2007). Social deficits in BTBR T+tf/J mice are unchanged by cross‐fostering with C57BL/6J mothers. International Journal of Developmental Neuroscience, 25, 515–521.17980995, Yang, M. , Zhodzishsky, V. , & Crawley, J. N. (2007). Social deficits in BTBR T+tf/J mice are unchanged by cross‐fostering with C57BL/6J mothers. International Journal of Developmental Neuroscience, 25, 515–521.17980995
( Ehninger, D. , Han, S. , Shilyansky, C. , Zhou, Y. , Li, W. , Kwiatkowski, D. J. , … Silva, A. J. (2008). Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis. Nature Medicine, 14, 843–848.)
Ehninger, D. , Han, S. , Shilyansky, C. , Zhou, Y. , Li, W. , Kwiatkowski, D. J. , … Silva, A. J. (2008). Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis. Nature Medicine, 14, 843–848.
Ehninger, D. , Han, S. , Shilyansky, C. , Zhou, Y. , Li, W. , Kwiatkowski, D. J. , … Silva, A. J. (2008). Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis. Nature Medicine, 14, 843–848., Ehninger, D. , Han, S. , Shilyansky, C. , Zhou, Y. , Li, W. , Kwiatkowski, D. J. , … Silva, A. J. (2008). Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis. Nature Medicine, 14, 843–848.
(2016)
High-frequency stimulation at the subthalamic nucleus suppresses excessive self-grooming in autism-like mouse
( Elfline, G. S. , Branda, E. M. , Babich, M. , & Quock, R. M. (2004). Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus‐maze. Neuropsychopharmacology, 29, 1419–1425.15136793)
Elfline, G. S. , Branda, E. M. , Babich, M. , & Quock, R. M. (2004). Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus‐maze. Neuropsychopharmacology, 29, 1419–1425.15136793
Elfline, G. S. , Branda, E. M. , Babich, M. , & Quock, R. M. (2004). Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus‐maze. Neuropsychopharmacology, 29, 1419–1425.15136793, Elfline, G. S. , Branda, E. M. , Babich, M. , & Quock, R. M. (2004). Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus‐maze. Neuropsychopharmacology, 29, 1419–1425.15136793
Lara Duffney, P. Zhong, Jing Wei, Emmanuel Matas, Jia Cheng, Luye Qin, Kaijie Ma, D. Dietz, Y. Kajiwara, J. Buxbaum, Zhen Yan (2015)
Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators.
Cell reports, 11 9
B. Pearson, R. Pobbe, E. Defensor, L. Oasay, V. Bolivar, V. Bolivar, D. Blanchard, R. Blanchard (2011)
Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism
Genes, 10
B. O’Roak, B. O’Roak, H. Stessman, E. Boyle, Kali Witherspoon, Benjamin Martin, Choli Lee, Laura Vives, Carl Baker, Joseph Hiatt, D. Nickerson, R. Bernier, J. Shendure, Evan Eichler (2014)
Recurrent de novo mutations implicate novel genes underlying simplex autism risk
Nature communications, 5
L. Torre-Ubieta, H. Won, J. Stein, D. Geschwind (2016)
Advancing the understanding of autism disease mechanisms through genetics
Nature Medicine, 22
( Duffney, L. J. , Zhong, P. , Wei, J. , Matas, E. , Cheng, J. , Qin, L. , … Yan, Z. (2015). Autism‐like deficits in Shank3‐deficient mice are rescued by targeting actin regulators. Cell Reports, 11, 1400–1413.26027926)
Duffney, L. J. , Zhong, P. , Wei, J. , Matas, E. , Cheng, J. , Qin, L. , … Yan, Z. (2015). Autism‐like deficits in Shank3‐deficient mice are rescued by targeting actin regulators. Cell Reports, 11, 1400–1413.26027926
Duffney, L. J. , Zhong, P. , Wei, J. , Matas, E. , Cheng, J. , Qin, L. , … Yan, Z. (2015). Autism‐like deficits in Shank3‐deficient mice are rescued by targeting actin regulators. Cell Reports, 11, 1400–1413.26027926, Duffney, L. J. , Zhong, P. , Wei, J. , Matas, E. , Cheng, J. , Qin, L. , … Yan, Z. (2015). Autism‐like deficits in Shank3‐deficient mice are rescued by targeting actin regulators. Cell Reports, 11, 1400–1413.26027926
( Pobbe, R. L. , Pearson, B. L. , Defensor, E. B. , Bolivar, V. J. , Blanchard, D. C. , & Blanchard, R. J. (2010). Expression of social behaviors of C57BL/6J versus BTBR inbred mouse strains in the visible burrow system. Behavioural Brain Research, 214, 443–449.20600340)
Pobbe, R. L. , Pearson, B. L. , Defensor, E. B. , Bolivar, V. J. , Blanchard, D. C. , & Blanchard, R. J. (2010). Expression of social behaviors of C57BL/6J versus BTBR inbred mouse strains in the visible burrow system. Behavioural Brain Research, 214, 443–449.20600340
Pobbe, R. L. , Pearson, B. L. , Defensor, E. B. , Bolivar, V. J. , Blanchard, D. C. , & Blanchard, R. J. (2010). Expression of social behaviors of C57BL/6J versus BTBR inbred mouse strains in the visible burrow system. Behavioural Brain Research, 214, 443–449.20600340, Pobbe, R. L. , Pearson, B. L. , Defensor, E. B. , Bolivar, V. J. , Blanchard, D. C. , & Blanchard, R. J. (2010). Expression of social behaviors of C57BL/6J versus BTBR inbred mouse strains in the visible burrow system. Behavioural Brain Research, 214, 443–449.20600340
C. Lord, R. Jones (2013)
New strategies and findings for behavioral interventions in autism spectrum disorders
Annals of the New York Academy of Sciences, 1304
R. Seese, A. Maske, G. Lynch, C. Gall (2014)
Long-Term Memory Deficits are Associated with Elevated Synaptic ERK1/2 Activation and Reversed by mGluR5 Antagonism in an Animal Model of Autism
Neuropsychopharmacology, 39
E. Bollen, Tim Vanmierlo, S. Akkerman, C. Wouters, H. Steinbusch, Jos Prickaerts (2013)
7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice
Behavioural Brain Research, 257
M. Baxter, T. Lanthorn, K. Frick, S. Golski, R. Wan, D. Olton (1994)
D-cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats
Neurobiology of Aging, 15
( Peca, J. , Feliciano, C. , Ting, J. T. , Wang, W. , Wells, M. F. , Venkatraman, T. N. , … Feng, G. (2011). Shank3 mutant mice display autistic‐like behaviours and striatal dysfunction. Nature, 472, 437–442.21423165)
Peca, J. , Feliciano, C. , Ting, J. T. , Wang, W. , Wells, M. F. , Venkatraman, T. N. , … Feng, G. (2011). Shank3 mutant mice display autistic‐like behaviours and striatal dysfunction. Nature, 472, 437–442.21423165
Peca, J. , Feliciano, C. , Ting, J. T. , Wang, W. , Wells, M. F. , Venkatraman, T. N. , … Feng, G. (2011). Shank3 mutant mice display autistic‐like behaviours and striatal dysfunction. Nature, 472, 437–442.21423165, Peca, J. , Feliciano, C. , Ting, J. T. , Wang, W. , Wells, M. F. , Venkatraman, T. N. , … Feng, G. (2011). Shank3 mutant mice display autistic‐like behaviours and striatal dysfunction. Nature, 472, 437–442.21423165
(2004)
Antagonism by NOS inhibition of the behavioral effects of benzodiazepine andGABAA receptor agonists
S. Dhamne, J. Silverman, Chloe Super, Stephen Lammers, M. Hameed, Meera Modi, N. Copping, M. Pride, Daniel Smith, A. Rotenberg, J. Crawley, M. Sahin (2017)
Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism
Molecular Autism, 8
D. Stephenson, Sharon O'Neill, Sapna Narayan, A. Tiwari, Elizabeth Arnold, Harry Samaroo, F. Du, R. Ring, Brian Campbell, M. Pletcher, V. Vaidya, D. Morton (2011)
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis
Molecular Autism, 2
( Betancur, C. , & Buxbaum, J. D. (2013). SHANK3 haploinsufficiency: A "common" but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders. Molecular Autism, 4, 17.23758743)
Betancur, C. , & Buxbaum, J. D. (2013). SHANK3 haploinsufficiency: A "common" but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders. Molecular Autism, 4, 17.23758743
Betancur, C. , & Buxbaum, J. D. (2013). SHANK3 haploinsufficiency: A "common" but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders. Molecular Autism, 4, 17.23758743, Betancur, C. , & Buxbaum, J. D. (2013). SHANK3 haploinsufficiency: A "common" but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders. Molecular Autism, 4, 17.23758743
N. Brown, J. Kerby, T. Bonnert, P. Whiting, K. Wafford (2002)
Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors
British Journal of Pharmacology, 136
( Chang, A. D. , Berges, V. A. , Chung, S. J. , Fridman, G. Y. , Baraban, J. M. , & Reti, I. M. (2016). High‐frequency stimulation at the subthalamic nucleus suppresses excessive self‐grooming in autism‐like mouse models. Neuropsychopharmacology, 41, 1813–1821.26606849)
Chang, A. D. , Berges, V. A. , Chung, S. J. , Fridman, G. Y. , Baraban, J. M. , & Reti, I. M. (2016). High‐frequency stimulation at the subthalamic nucleus suppresses excessive self‐grooming in autism‐like mouse models. Neuropsychopharmacology, 41, 1813–1821.26606849
Chang, A. D. , Berges, V. A. , Chung, S. J. , Fridman, G. Y. , Baraban, J. M. , & Reti, I. M. (2016). High‐frequency stimulation at the subthalamic nucleus suppresses excessive self‐grooming in autism‐like mouse models. Neuropsychopharmacology, 41, 1813–1821.26606849, Chang, A. D. , Berges, V. A. , Chung, S. J. , Fridman, G. Y. , Baraban, J. M. , & Reti, I. M. (2016). High‐frequency stimulation at the subthalamic nucleus suppresses excessive self‐grooming in autism‐like mouse models. Neuropsychopharmacology, 41, 1813–1821.26606849
T. Lipina, Karin Weiss, J. Roder (2007)
The Ampakine CX546 Restores the Prepulse Inhibition and Latent Inhibition Deficits in mGluR5-Deficient Mice
Neuropsychopharmacology, 32
( Schade, S. , & Paulus, W. (2016). D‐cycloserine in neuropsychiatric diseases: A systematic review. The International Journal of Neuropsychopharmacology, 19, pyv102.26364274)
Schade, S. , & Paulus, W. (2016). D‐cycloserine in neuropsychiatric diseases: A systematic review. The International Journal of Neuropsychopharmacology, 19, pyv102.26364274
Schade, S. , & Paulus, W. (2016). D‐cycloserine in neuropsychiatric diseases: A systematic review. The International Journal of Neuropsychopharmacology, 19, pyv102.26364274, Schade, S. , & Paulus, W. (2016). D‐cycloserine in neuropsychiatric diseases: A systematic review. The International Journal of Neuropsychopharmacology, 19, pyv102.26364274
( Stagni, F. , Giacomini, A. , Guidi, S. , Emili, M. , Uguagliati, B. , Salvalai, M. E. , … Bartesaghi, R. (2017). A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus‐dependent memory in the Ts65Dn mouse model of DS. Experimental Neurology, 298, 79–96.28882412)
Stagni, F. , Giacomini, A. , Guidi, S. , Emili, M. , Uguagliati, B. , Salvalai, M. E. , … Bartesaghi, R. (2017). A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus‐dependent memory in the Ts65Dn mouse model of DS. Experimental Neurology, 298, 79–96.28882412
Stagni, F. , Giacomini, A. , Guidi, S. , Emili, M. , Uguagliati, B. , Salvalai, M. E. , … Bartesaghi, R. (2017). A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus‐dependent memory in the Ts65Dn mouse model of DS. Experimental Neurology, 298, 79–96.28882412, Stagni, F. , Giacomini, A. , Guidi, S. , Emili, M. , Uguagliati, B. , Salvalai, M. E. , … Bartesaghi, R. (2017). A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus‐dependent memory in the Ts65Dn mouse model of DS. Experimental Neurology, 298, 79–96.28882412
T. Lanthorn (1994)
D-Cycloserine: Agonist turned antagonist
Amino Acids, 6
( Waszczak, B. L. , Hruska, R. E. , & Walters, J. R. (1980). GABAergic actions of THIP in vivo and vitro: A comparison with muscimol and GABA. European Journal of Pharmacology, 65, 21–29.7398775)
Waszczak, B. L. , Hruska, R. E. , & Walters, J. R. (1980). GABAergic actions of THIP in vivo and vitro: A comparison with muscimol and GABA. European Journal of Pharmacology, 65, 21–29.7398775
Waszczak, B. L. , Hruska, R. E. , & Walters, J. R. (1980). GABAergic actions of THIP in vivo and vitro: A comparison with muscimol and GABA. European Journal of Pharmacology, 65, 21–29.7398775, Waszczak, B. L. , Hruska, R. E. , & Walters, J. R. (1980). GABAergic actions of THIP in vivo and vitro: A comparison with muscimol and GABA. European Journal of Pharmacology, 65, 21–29.7398775
( Yoshimura, R. F. , Tran, M. B. , Hogenkamp, D. J. , Ayala, N. L. , Johnstone, T. , Dunnigan, A. J. , … Gee, K. W. (2017). Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism‐like behaviors in the BTBR mouse model. Neuropharmacology, 126, 38–47.28842344)
Yoshimura, R. F. , Tran, M. B. , Hogenkamp, D. J. , Ayala, N. L. , Johnstone, T. , Dunnigan, A. J. , … Gee, K. W. (2017). Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism‐like behaviors in the BTBR mouse model. Neuropharmacology, 126, 38–47.28842344
Yoshimura, R. F. , Tran, M. B. , Hogenkamp, D. J. , Ayala, N. L. , Johnstone, T. , Dunnigan, A. J. , … Gee, K. W. (2017). Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism‐like behaviors in the BTBR mouse model. Neuropharmacology, 126, 38–47.28842344, Yoshimura, R. F. , Tran, M. B. , Hogenkamp, D. J. , Ayala, N. L. , Johnstone, T. , Dunnigan, A. J. , … Gee, K. W. (2017). Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism‐like behaviors in the BTBR mouse model. Neuropharmacology, 126, 38–47.28842344
( Yuen, R. K. , Merico, D. , Bookman, M. L. , Howe, J., Thiruvahindrapuram, B., Patel, R. V., … Scherer, S. W. (2017). Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nature Neuroscience, 20, 602–611.28263302)
Yuen, R. K. , Merico, D. , Bookman, M. L. , Howe, J., Thiruvahindrapuram, B., Patel, R. V., … Scherer, S. W. (2017). Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nature Neuroscience, 20, 602–611.28263302
Yuen, R. K. , Merico, D. , Bookman, M. L. , Howe, J., Thiruvahindrapuram, B., Patel, R. V., … Scherer, S. W. (2017). Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nature Neuroscience, 20, 602–611.28263302, Yuen, R. K. , Merico, D. , Bookman, M. L. , Howe, J., Thiruvahindrapuram, B., Patel, R. V., … Scherer, S. W. (2017). Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nature Neuroscience, 20, 602–611.28263302
Nicholas Castello, Michael Nguyen, Jenny Tran, David Cheng, K. Green, F. LaFerla (2014)
7,8-Dihydroxyflavone, a Small Molecule TrkB Agonist, Improves Spatial Memory and Increases Thin Spine Density in a Mouse Model of Alzheimer Disease-Like Neuronal Loss
PLoS ONE, 9
( Sanders, S. J. , He, X. , Willsey, A. J. , Ercan‐Sencicek, A. G. , Samocha, K. E. , Cicek, A. E. , … State, M. W. (2015). Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron, 87, 1215–1233.26402605)
Sanders, S. J. , He, X. , Willsey, A. J. , Ercan‐Sencicek, A. G. , Samocha, K. E. , Cicek, A. E. , … State, M. W. (2015). Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron, 87, 1215–1233.26402605
Sanders, S. J. , He, X. , Willsey, A. J. , Ercan‐Sencicek, A. G. , Samocha, K. E. , Cicek, A. E. , … State, M. W. (2015). Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron, 87, 1215–1233.26402605, Sanders, S. J. , He, X. , Willsey, A. J. , Ercan‐Sencicek, A. G. , Samocha, K. E. , Cicek, A. E. , … State, M. W. (2015). Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron, 87, 1215–1233.26402605
M. Ramaker, M. Ford, T. Phillips, D. Finn (2014)
Differences in the reinstatement of ethanol seeking with ganaxolone and gaboxadol
Neuroscience, 272
Jill Silverman, Chicora Oliver, Michael Karras, P. Gastrell, J. Crawley (2013)
AMPAKINE enhancement of social interaction in the BTBR mouse model of autism
Neuropharmacology, 64
V. Bolivar, S. Walters, J. Phoenix (2007)
Assessing autism-like behavior in mice: Variations in social interactions among inbred strains
Behavioural Brain Research, 176
M. Phillips, L. Pozzo-Miller (2015)
Dendritic spine dysgenesis in autism related disorders
Neuroscience Letters, 601
( Pinto, D. , Delaby, E. , Merico, D. , Barbosa, M. , Merikangas, A. , Klei, L. , … Scherer, S. W. (2014). Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. American Journal of Human Genetics, 94, 677–694.24768552)
Pinto, D. , Delaby, E. , Merico, D. , Barbosa, M. , Merikangas, A. , Klei, L. , … Scherer, S. W. (2014). Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. American Journal of Human Genetics, 94, 677–694.24768552
Pinto, D. , Delaby, E. , Merico, D. , Barbosa, M. , Merikangas, A. , Klei, L. , … Scherer, S. W. (2014). Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. American Journal of Human Genetics, 94, 677–694.24768552, Pinto, D. , Delaby, E. , Merico, D. , Barbosa, M. , Merikangas, A. , Klei, L. , … Scherer, S. W. (2014). Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. American Journal of Human Genetics, 94, 677–694.24768552
( Scattoni, M. L. , Martire, A. , Cartocci, G. , Ferrante, A. , & Ricceri, L. (2013). Reduced social interaction, behavioural flexibility and BDNF signalling in the BTBR T+ tf/J strain, a mouse model of autism. Behavioural Brain Research, 251, 35–40.23270976)
Scattoni, M. L. , Martire, A. , Cartocci, G. , Ferrante, A. , & Ricceri, L. (2013). Reduced social interaction, behavioural flexibility and BDNF signalling in the BTBR T+ tf/J strain, a mouse model of autism. Behavioural Brain Research, 251, 35–40.23270976
Scattoni, M. L. , Martire, A. , Cartocci, G. , Ferrante, A. , & Ricceri, L. (2013). Reduced social interaction, behavioural flexibility and BDNF signalling in the BTBR T+ tf/J strain, a mouse model of autism. Behavioural Brain Research, 251, 35–40.23270976, Scattoni, M. L. , Martire, A. , Cartocci, G. , Ferrante, A. , & Ricceri, L. (2013). Reduced social interaction, behavioural flexibility and BDNF signalling in the BTBR T+ tf/J strain, a mouse model of autism. Behavioural Brain Research, 251, 35–40.23270976
( Sato, A. , Kasai, S. , Kobayashi, T. , Takamatsu, Y. , Hino, O. , Ikeda, K. , & Mizuguchi, M. (2012). Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nature Communications, 3(1292), 1292.)
Sato, A. , Kasai, S. , Kobayashi, T. , Takamatsu, Y. , Hino, O. , Ikeda, K. , & Mizuguchi, M. (2012). Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nature Communications, 3(1292), 1292.
Sato, A. , Kasai, S. , Kobayashi, T. , Takamatsu, Y. , Hino, O. , Ikeda, K. , & Mizuguchi, M. (2012). Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nature Communications, 3(1292), 1292., Sato, A. , Kasai, S. , Kobayashi, T. , Takamatsu, Y. , Hino, O. , Ikeda, K. , & Mizuguchi, M. (2012). Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nature Communications, 3(1292), 1292.
( Lipina, T. , Weiss, K. , & Roder, J. (2007). The ampakine CX546 restores the prepulse inhibition and latent inhibition deficits in mGluR5‐deficient mice. Neuropsychopharmacology, 32, 745–756.16936708)
Lipina, T. , Weiss, K. , & Roder, J. (2007). The ampakine CX546 restores the prepulse inhibition and latent inhibition deficits in mGluR5‐deficient mice. Neuropsychopharmacology, 32, 745–756.16936708
Lipina, T. , Weiss, K. , & Roder, J. (2007). The ampakine CX546 restores the prepulse inhibition and latent inhibition deficits in mGluR5‐deficient mice. Neuropsychopharmacology, 32, 745–756.16936708, Lipina, T. , Weiss, K. , & Roder, J. (2007). The ampakine CX546 restores the prepulse inhibition and latent inhibition deficits in mGluR5‐deficient mice. Neuropsychopharmacology, 32, 745–756.16936708
( White, R. W. , Prasad, M. , Barfield, R. J. , & Nyby, J. G. (1998). 40‐ and 70‐kHz vocalizations of mice (Mus musculus) during copulation. Physiology & Behavior, 63, 467–473.9523885)
White, R. W. , Prasad, M. , Barfield, R. J. , & Nyby, J. G. (1998). 40‐ and 70‐kHz vocalizations of mice (Mus musculus) during copulation. Physiology & Behavior, 63, 467–473.9523885
White, R. W. , Prasad, M. , Barfield, R. J. , & Nyby, J. G. (1998). 40‐ and 70‐kHz vocalizations of mice (Mus musculus) during copulation. Physiology & Behavior, 63, 467–473.9523885, White, R. W. , Prasad, M. , Barfield, R. J. , & Nyby, J. G. (1998). 40‐ and 70‐kHz vocalizations of mice (Mus musculus) during copulation. Physiology & Behavior, 63, 467–473.9523885
P. Meera, M. Wallner, T. Otis (2011)
Molecular basis for the high THIP/gaboxadol sensitivity of extrasynaptic GABA(A) receptors.
Journal of neurophysiology, 106 4
( Stoppel, L. J. , Kazdoba, T. M. , Schaffler, M. D. , Prez, A. R. , Heynen, A. , Crawley, J. N. , & Bear, M. F. (2018). R‐baclofen reverses cognitive deficits and improves social interactions in two lines of 16p11.2 deletion mice. Neuropsychopharmacology, 43, 513–524.28984295)
Stoppel, L. J. , Kazdoba, T. M. , Schaffler, M. D. , Prez, A. R. , Heynen, A. , Crawley, J. N. , & Bear, M. F. (2018). R‐baclofen reverses cognitive deficits and improves social interactions in two lines of 16p11.2 deletion mice. Neuropsychopharmacology, 43, 513–524.28984295
Stoppel, L. J. , Kazdoba, T. M. , Schaffler, M. D. , Prez, A. R. , Heynen, A. , Crawley, J. N. , & Bear, M. F. (2018). R‐baclofen reverses cognitive deficits and improves social interactions in two lines of 16p11.2 deletion mice. Neuropsychopharmacology, 43, 513–524.28984295, Stoppel, L. J. , Kazdoba, T. M. , Schaffler, M. D. , Prez, A. R. , Heynen, A. , Crawley, J. N. , & Bear, M. F. (2018). R‐baclofen reverses cognitive deficits and improves social interactions in two lines of 16p11.2 deletion mice. Neuropsychopharmacology, 43, 513–524.28984295
C. Björkholm, L. Monteggia (2016)
BDNF – a key transducer of antidepressant effects
Neuropharmacology, 102
Chase Carver, D. Reddy (2013)
Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability
Psychopharmacology, 230
( Lee, J. , Chung, C. , Ha, S. , Lee, D. , Kim, D. Y. , Kim, H. , & Kim, E. (2015). Shank3‐mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit. Frontiers in Cellular Neuroscience, 9, 94.25852484)
Lee, J. , Chung, C. , Ha, S. , Lee, D. , Kim, D. Y. , Kim, H. , & Kim, E. (2015). Shank3‐mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit. Frontiers in Cellular Neuroscience, 9, 94.25852484
Lee, J. , Chung, C. , Ha, S. , Lee, D. , Kim, D. Y. , Kim, H. , & Kim, E. (2015). Shank3‐mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit. Frontiers in Cellular Neuroscience, 9, 94.25852484, Lee, J. , Chung, C. , Ha, S. , Lee, D. , Kim, D. Y. , Kim, H. , & Kim, E. (2015). Shank3‐mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit. Frontiers in Cellular Neuroscience, 9, 94.25852484
Jessica Burket, A. Benson, Amy Tang, S. Deutsch (2013)
d-Cycloserine improves sociability in the BTBR T+ Itpr3tf/J mouse model of autism spectrum disorders with altered Ras/Raf/ERK1/2 signaling
Brain Research Bulletin, 96
( Frye, C. A. , & Llaneza, D. C. (2010). Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice. Physiology & Behavior, 100, 264–267.20298706)
Frye, C. A. , & Llaneza, D. C. (2010). Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice. Physiology & Behavior, 100, 264–267.20298706
Frye, C. A. , & Llaneza, D. C. (2010). Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice. Physiology & Behavior, 100, 264–267.20298706, Frye, C. A. , & Llaneza, D. C. (2010). Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice. Physiology & Behavior, 100, 264–267.20298706
( Leach, P. T. , & Crawley, J. N. (2018). Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities. Genes, Brain, and Behavior, 17, e12452.)
Leach, P. T. , & Crawley, J. N. (2018). Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities. Genes, Brain, and Behavior, 17, e12452.
Leach, P. T. , & Crawley, J. N. (2018). Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities. Genes, Brain, and Behavior, 17, e12452., Leach, P. T. , & Crawley, J. N. (2018). Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities. Genes, Brain, and Behavior, 17, e12452.
P. Washbourne (2015)
Synapse Assembly and Neurodevelopmental Disorders
Neuropsychopharmacology, 40
( Spooren, W. , Lindemann, L. , Ghosh, A. , & Santarelli, L. (2012). Synapse dysfunction in autism: A molecular medicine approach to drug discovery in neurodevelopmental disorders. Trends in Pharmacological Sciences, 33, 669–684.23084458)
Spooren, W. , Lindemann, L. , Ghosh, A. , & Santarelli, L. (2012). Synapse dysfunction in autism: A molecular medicine approach to drug discovery in neurodevelopmental disorders. Trends in Pharmacological Sciences, 33, 669–684.23084458
Spooren, W. , Lindemann, L. , Ghosh, A. , & Santarelli, L. (2012). Synapse dysfunction in autism: A molecular medicine approach to drug discovery in neurodevelopmental disorders. Trends in Pharmacological Sciences, 33, 669–684.23084458, Spooren, W. , Lindemann, L. , Ghosh, A. , & Santarelli, L. (2012). Synapse dysfunction in autism: A molecular medicine approach to drug discovery in neurodevelopmental disorders. Trends in Pharmacological Sciences, 33, 669–684.23084458
( Iversen, L. (2004). GABA pharmacology—What prospects for the future? Biochemical Pharmacology, 68, 1537–1540.15451396)
Iversen, L. (2004). GABA pharmacology—What prospects for the future? Biochemical Pharmacology, 68, 1537–1540.15451396
Iversen, L. (2004). GABA pharmacology—What prospects for the future? Biochemical Pharmacology, 68, 1537–1540.15451396, Iversen, L. (2004). GABA pharmacology—What prospects for the future? Biochemical Pharmacology, 68, 1537–1540.15451396
E. Lemonnier, C. Degrez, Morgane Phelep, R. Tyzio, F. Josse, M. Grandgeorge, N. Hadjikhani, N. Hadjikhani, Y. Ben-Ari (2012)
A randomised controlled trial of bumetanide in the treatment of autism in children
Translational Psychiatry, 2
D. Ehninger, Sangyeul Han, C. Shilyansky, Yu Zhou, Weidong Li, D. Kwiatkowski, V. Ramesh, Alcino Silva (2008)
Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Nature Medicine, 14
E. Defensor, B. Pearson, R. Pobbe, V. Bolivar, D., Caroline Blanchard, R. Blanchard (2011)
A novel social proximity test suggests patterns of social avoidance and gaze aversion-like behavior in BTBR T+ tf/J mice
Behavioural Brain Research, 217
P. Crino (2011)
mTOR: A pathogenic signaling pathway in developmental brain malformations.
Trends in molecular medicine, 17 12
( Schoch, H. , Kreibich, A. S. , Ferri, S. L. , White, R. S. , Bohorquez, D. , Banerjee, A. , … Brodkin, E. (2017). Sociability deficits and altered amygdala circuits in mice lacking Pcdh10, an autism associated gene. Biological Psychiatry, 81, 193–202.27567313)
Schoch, H. , Kreibich, A. S. , Ferri, S. L. , White, R. S. , Bohorquez, D. , Banerjee, A. , … Brodkin, E. (2017). Sociability deficits and altered amygdala circuits in mice lacking Pcdh10, an autism associated gene. Biological Psychiatry, 81, 193–202.27567313
Schoch, H. , Kreibich, A. S. , Ferri, S. L. , White, R. S. , Bohorquez, D. , Banerjee, A. , … Brodkin, E. (2017). Sociability deficits and altered amygdala circuits in mice lacking Pcdh10, an autism associated gene. Biological Psychiatry, 81, 193–202.27567313, Schoch, H. , Kreibich, A. S. , Ferri, S. L. , White, R. S. , Bohorquez, D. , Banerjee, A. , … Brodkin, E. (2017). Sociability deficits and altered amygdala circuits in mice lacking Pcdh10, an autism associated gene. Biological Psychiatry, 81, 193–202.27567313
( Moy, S. S. , Nadler, J. J. , Young, N. B. , Perez, A. , Holloway, L. P. , Barbaro, R. P. , … Crawley, J. N. (2007). Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains. Behavioural Brain Research, 176, 4–20.16971002)
Moy, S. S. , Nadler, J. J. , Young, N. B. , Perez, A. , Holloway, L. P. , Barbaro, R. P. , … Crawley, J. N. (2007). Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains. Behavioural Brain Research, 176, 4–20.16971002
Moy, S. S. , Nadler, J. J. , Young, N. B. , Perez, A. , Holloway, L. P. , Barbaro, R. P. , … Crawley, J. N. (2007). Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains. Behavioural Brain Research, 176, 4–20.16971002, Moy, S. S. , Nadler, J. J. , Young, N. B. , Perez, A. , Holloway, L. P. , Barbaro, R. P. , … Crawley, J. N. (2007). Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains. Behavioural Brain Research, 176, 4–20.16971002
( Holmes, A. , & Rodgers, R. J. (1998). Responses of Swiss‐Webster mice to repeated plus‐maze experience: Further evidence for a qualitative shift in emotional state? Pharmacology, Biochemistry, and Behavior, 60, 473–488.)
Holmes, A. , & Rodgers, R. J. (1998). Responses of Swiss‐Webster mice to repeated plus‐maze experience: Further evidence for a qualitative shift in emotional state? Pharmacology, Biochemistry, and Behavior, 60, 473–488.
Holmes, A. , & Rodgers, R. J. (1998). Responses of Swiss‐Webster mice to repeated plus‐maze experience: Further evidence for a qualitative shift in emotional state? Pharmacology, Biochemistry, and Behavior, 60, 473–488., Holmes, A. , & Rodgers, R. J. (1998). Responses of Swiss‐Webster mice to repeated plus‐maze experience: Further evidence for a qualitative shift in emotional state? Pharmacology, Biochemistry, and Behavior, 60, 473–488.
M. Davis, K. Ressler, B. Rothbaum, R. Richardson (2006)
Effects of D-Cycloserine on Extinction: Translation From Preclinical to Clinical Work
Biological Psychiatry, 60
( Olmos‐Serrano, J. L. , Corbin, J. G. , & Burns, M. P. (2011). The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Developmental Neuroscience, 33, 395–403.22067669)
Olmos‐Serrano, J. L. , Corbin, J. G. , & Burns, M. P. (2011). The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Developmental Neuroscience, 33, 395–403.22067669
Olmos‐Serrano, J. L. , Corbin, J. G. , & Burns, M. P. (2011). The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Developmental Neuroscience, 33, 395–403.22067669, Olmos‐Serrano, J. L. , Corbin, J. G. , & Burns, M. P. (2011). The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Developmental Neuroscience, 33, 395–403.22067669
( Arai, A. C. , & Kessler, M. (2007). Pharmacology of ampakine modulators: From AMPA receptors to synapses and behavior. Current Drug Targets, 8, 583–602.17504103)
Arai, A. C. , & Kessler, M. (2007). Pharmacology of ampakine modulators: From AMPA receptors to synapses and behavior. Current Drug Targets, 8, 583–602.17504103
Arai, A. C. , & Kessler, M. (2007). Pharmacology of ampakine modulators: From AMPA receptors to synapses and behavior. Current Drug Targets, 8, 583–602.17504103, Arai, A. C. , & Kessler, M. (2007). Pharmacology of ampakine modulators: From AMPA receptors to synapses and behavior. Current Drug Targets, 8, 583–602.17504103
T. Bourgeron (2009)
A synaptic trek to autism
Current Opinion in Neurobiology, 19
P. Buckley (2007)
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat StressBerton O, McClung CA, DiLeone RJ, et al (Univ of Texas Southwestern Med Ctr, Dallas; Tufts Univ School of Medicine, Boston) Science 311:864–868, 2006§
Yearbook of Psychiatry and Applied Mental Health
Adam Steinmetz, Sarah Stern, Amy Kohtz, G. Descalzi, C. Alberini (2017)
Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice
The Journal of Neuroscience, 38
J. Silverman, Daniel Smith, S. Rizzo, Michael Karras, S. Turner, Seda Tolu, D. Bryce, Deborah Smith, Kari Fonseca, R. Ring, J. Crawley (2012)
Negative Allosteric Modulation of the mGluR5 Receptor Reduces Repetitive Behaviors and Rescues Social Deficits in Mouse Models of Autism
Science Translational Medicine, 4
( Goff, D. C. , Leahy, L. , Berman, I. , Posever, T. , Herz, L. , Leon, A. C. , … Lynch, G. (2001). A placebo‐controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. Journal of Clinical Psychopharmacology, 21, 484–487.11593073)
Goff, D. C. , Leahy, L. , Berman, I. , Posever, T. , Herz, L. , Leon, A. C. , … Lynch, G. (2001). A placebo‐controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. Journal of Clinical Psychopharmacology, 21, 484–487.11593073
Goff, D. C. , Leahy, L. , Berman, I. , Posever, T. , Herz, L. , Leon, A. C. , … Lynch, G. (2001). A placebo‐controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. Journal of Clinical Psychopharmacology, 21, 484–487.11593073, Goff, D. C. , Leahy, L. , Berman, I. , Posever, T. , Herz, L. , Leon, A. C. , … Lynch, G. (2001). A placebo‐controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. Journal of Clinical Psychopharmacology, 21, 484–487.11593073
( Bateup, H. S. , Johnson, C. A. , Denefrio, C. L. , Saulnier, J. L. , Kornacker, K. , & Sabatini, B. L. (2013). Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron, 78, 510–522.23664616)
Bateup, H. S. , Johnson, C. A. , Denefrio, C. L. , Saulnier, J. L. , Kornacker, K. , & Sabatini, B. L. (2013). Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron, 78, 510–522.23664616
Bateup, H. S. , Johnson, C. A. , Denefrio, C. L. , Saulnier, J. L. , Kornacker, K. , & Sabatini, B. L. (2013). Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron, 78, 510–522.23664616, Bateup, H. S. , Johnson, C. A. , Denefrio, C. L. , Saulnier, J. L. , Kornacker, K. , & Sabatini, B. L. (2013). Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron, 78, 510–522.23664616
( Silverman, J. L. , Yang, M. , Turner, S. M. , Katz, A. M. , Bell, D. B. , Koenig, J. L. , & Crawley, J. N. (2010). Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism. Neuroscience, 171, 1197–1208.20888890)
Silverman, J. L. , Yang, M. , Turner, S. M. , Katz, A. M. , Bell, D. B. , Koenig, J. L. , & Crawley, J. N. (2010). Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism. Neuroscience, 171, 1197–1208.20888890
Silverman, J. L. , Yang, M. , Turner, S. M. , Katz, A. M. , Bell, D. B. , Koenig, J. L. , & Crawley, J. N. (2010). Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism. Neuroscience, 171, 1197–1208.20888890, Silverman, J. L. , Yang, M. , Turner, S. M. , Katz, A. M. , Bell, D. B. , Koenig, J. L. , & Crawley, J. N. (2010). Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism. Neuroscience, 171, 1197–1208.20888890
J. Silverman, M. Pride, J. Hayes, Kyle Puhger, Hanna Butler-Struben, S. Baker, J. Crawley (2015)
GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism
Neuropsychopharmacology, 40
G. Lynch (2006)
Glutamate-based therapeutic approaches: ampakines.
Current opinion in pharmacology, 6 1
Miriam Kron, Min Lang, Ian Adams, M. Sceniak, F. Longo, D. Katz (2014)
A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome
Disease Models & Mechanisms, 7
W. Spooren, L. Lindemann, Anirvan Ghosh, L. Santarelli (2012)
Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders.
Trends in pharmacological sciences, 33 12
O. Berton, C. McClung, R. DiLeone, V. Krishnan, William Renthal, S. Russo, D. Graham, Nadia Tsankova, C. Bolaños, M. Rios, L. Monteggia, D. Self, E. Nestler (2006)
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress
Science, 311
( Ren, Q. , Zhang, J. C. , Ma, M. , Fujita, Y. , Wu, J. , & Hashimoto, K. (2014). 7,8‐Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine. Psychopharmacology, 231, 159–166.23934209)
Ren, Q. , Zhang, J. C. , Ma, M. , Fujita, Y. , Wu, J. , & Hashimoto, K. (2014). 7,8‐Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine. Psychopharmacology, 231, 159–166.23934209
Ren, Q. , Zhang, J. C. , Ma, M. , Fujita, Y. , Wu, J. , & Hashimoto, K. (2014). 7,8‐Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine. Psychopharmacology, 231, 159–166.23934209, Ren, Q. , Zhang, J. C. , Ma, M. , Fujita, Y. , Wu, J. , & Hashimoto, K. (2014). 7,8‐Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine. Psychopharmacology, 231, 159–166.23934209
( Farrant, M. , & Nusser, Z. (2005). Variations on an inhibitory theme: Phasic and tonic activation of GABA(A) receptors. Nature Reviews. Neuroscience, 6, 215–229.15738957)
Farrant, M. , & Nusser, Z. (2005). Variations on an inhibitory theme: Phasic and tonic activation of GABA(A) receptors. Nature Reviews. Neuroscience, 6, 215–229.15738957
Farrant, M. , & Nusser, Z. (2005). Variations on an inhibitory theme: Phasic and tonic activation of GABA(A) receptors. Nature Reviews. Neuroscience, 6, 215–229.15738957, Farrant, M. , & Nusser, Z. (2005). Variations on an inhibitory theme: Phasic and tonic activation of GABA(A) receptors. Nature Reviews. Neuroscience, 6, 215–229.15738957
S. Rogers, L. Vismara, A. Wagner, Carolyn McCormick, G. Young, Sally Ozonoff (2014)
Autism Treatment in the First Year of Life: A Pilot Study of Infant Start, a Parent-Implemented Intervention for Symptomatic Infants
Journal of Autism and Developmental Disorders, 44
L. Iversen (2004)
GABA pharmacology--what prospects for the future?
Biochemical pharmacology, 68 8
( Kron, M. , Lang, M. , Adams, I. T. , Sceniak, M. , Longo, F. , & Katz, D. M. (2014). A BDNF loop‐domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome. Disease Models & Mechanisms, 7, 1047–1055.25147297)
Kron, M. , Lang, M. , Adams, I. T. , Sceniak, M. , Longo, F. , & Katz, D. M. (2014). A BDNF loop‐domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome. Disease Models & Mechanisms, 7, 1047–1055.25147297
Kron, M. , Lang, M. , Adams, I. T. , Sceniak, M. , Longo, F. , & Katz, D. M. (2014). A BDNF loop‐domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome. Disease Models & Mechanisms, 7, 1047–1055.25147297, Kron, M. , Lang, M. , Adams, I. T. , Sceniak, M. , Longo, F. , & Katz, D. M. (2014). A BDNF loop‐domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome. Disease Models & Mechanisms, 7, 1047–1055.25147297
( Tsai, P. T. , Hull, C. , Chu, Y. , Greene‐Colozzi, E. , Sadowski, A. R. , Leech, J. M. , … Sahin, M. (2012). Autistic‐like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature, 488, 647–651.22763451)
Tsai, P. T. , Hull, C. , Chu, Y. , Greene‐Colozzi, E. , Sadowski, A. R. , Leech, J. M. , … Sahin, M. (2012). Autistic‐like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature, 488, 647–651.22763451
Tsai, P. T. , Hull, C. , Chu, Y. , Greene‐Colozzi, E. , Sadowski, A. R. , Leech, J. M. , … Sahin, M. (2012). Autistic‐like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature, 488, 647–651.22763451, Tsai, P. T. , Hull, C. , Chu, Y. , Greene‐Colozzi, E. , Sadowski, A. R. , Leech, J. M. , … Sahin, M. (2012). Autistic‐like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature, 488, 647–651.22763451
P. Monteiro, G. Feng (2017)
SHANK proteins: roles at the synapse and in autism spectrum disorder
Nature Reviews Neuroscience, 18
( de la Torre‐Ubieta, L. , Won, H. , Stein, J. L. , & Geschwind, D. H. (2016). Advancing the understanding of autism disease mechanisms through genetics. Nature Medicine, 22, 345–361.)
de la Torre‐Ubieta, L. , Won, H. , Stein, J. L. , & Geschwind, D. H. (2016). Advancing the understanding of autism disease mechanisms through genetics. Nature Medicine, 22, 345–361.
de la Torre‐Ubieta, L. , Won, H. , Stein, J. L. , & Geschwind, D. H. (2016). Advancing the understanding of autism disease mechanisms through genetics. Nature Medicine, 22, 345–361., de la Torre‐Ubieta, L. , Won, H. , Stein, J. L. , & Geschwind, D. H. (2016). Advancing the understanding of autism disease mechanisms through genetics. Nature Medicine, 22, 345–361.
Karyn Myers, W. Carlezon (2012)
D-Cycloserine Effects on Extinction of Conditioned Responses to Drug-Related Cues
Biological Psychiatry, 71
( Jacquemont, S. , Berry‐Kravis, E. , Lindemann, L. , Jønch, A. , Apostol, G. , Bear, M. , … Spooren, W. (2018). Drug development for fragile X syndrome: Lessons learned and implications for treatment of neurodevelopmental disorders. Nature Reviews Drug Discovery, 17, 280–298.29217836)
Jacquemont, S. , Berry‐Kravis, E. , Lindemann, L. , Jønch, A. , Apostol, G. , Bear, M. , … Spooren, W. (2018). Drug development for fragile X syndrome: Lessons learned and implications for treatment of neurodevelopmental disorders. Nature Reviews Drug Discovery, 17, 280–298.29217836
Jacquemont, S. , Berry‐Kravis, E. , Lindemann, L. , Jønch, A. , Apostol, G. , Bear, M. , … Spooren, W. (2018). Drug development for fragile X syndrome: Lessons learned and implications for treatment of neurodevelopmental disorders. Nature Reviews Drug Discovery, 17, 280–298.29217836, Jacquemont, S. , Berry‐Kravis, E. , Lindemann, L. , Jønch, A. , Apostol, G. , Bear, M. , … Spooren, W. (2018). Drug development for fragile X syndrome: Lessons learned and implications for treatment of neurodevelopmental disorders. Nature Reviews Drug Discovery, 17, 280–298.29217836
A. Arai, Markus Kessler (2007)
Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior.
Current drug targets, 8 5
Mu Yang, V. Zhodzishsky, J. Crawley (2007)
Social deficits in BTBR T + tf/J mice are unchanged by cross-fostering with C57BL/6J mothers
International Journal of Developmental Neuroscience, 25
( Veenstra‐Vanderweele, J. , Cook, E. H. , King, B. H. , Zarevics, P. , Cherubini, M. , Walton‐Bowen, K. , … Carpenter, R. L. (2017). Arbaclofen in children and adolescents with autism spectrum disorder: A randomized, controlled, Phase 2 trial. Neuropsychopharmacology, 42, 1390–1398.27748740)
Veenstra‐Vanderweele, J. , Cook, E. H. , King, B. H. , Zarevics, P. , Cherubini, M. , Walton‐Bowen, K. , … Carpenter, R. L. (2017). Arbaclofen in children and adolescents with autism spectrum disorder: A randomized, controlled, Phase 2 trial. Neuropsychopharmacology, 42, 1390–1398.27748740
Veenstra‐Vanderweele, J. , Cook, E. H. , King, B. H. , Zarevics, P. , Cherubini, M. , Walton‐Bowen, K. , … Carpenter, R. L. (2017). Arbaclofen in children and adolescents with autism spectrum disorder: A randomized, controlled, Phase 2 trial. Neuropsychopharmacology, 42, 1390–1398.27748740, Veenstra‐Vanderweele, J. , Cook, E. H. , King, B. H. , Zarevics, P. , Cherubini, M. , Walton‐Bowen, K. , … Carpenter, R. L. (2017). Arbaclofen in children and adolescents with autism spectrum disorder: A randomized, controlled, Phase 2 trial. Neuropsychopharmacology, 42, 1390–1398.27748740
( Rosas‐Vidal, L. E. , Lozada‐Miranda, V. , Cantres‐Rosario, Y. , Vega‐Medina, A. , Melendez, L. , & Quirk, G. J. (2018). Alteration of BDNF in the medial prefrontal cortex and the ventral hippocampus impairs extinction of avoidance. Neuropsychopharmacology in press, 43, 2636–2644.30127343)
Rosas‐Vidal, L. E. , Lozada‐Miranda, V. , Cantres‐Rosario, Y. , Vega‐Medina, A. , Melendez, L. , & Quirk, G. J. (2018). Alteration of BDNF in the medial prefrontal cortex and the ventral hippocampus impairs extinction of avoidance. Neuropsychopharmacology in press, 43, 2636–2644.30127343
Rosas‐Vidal, L. E. , Lozada‐Miranda, V. , Cantres‐Rosario, Y. , Vega‐Medina, A. , Melendez, L. , & Quirk, G. J. (2018). Alteration of BDNF in the medial prefrontal cortex and the ventral hippocampus impairs extinction of avoidance. Neuropsychopharmacology in press, 43, 2636–2644.30127343, Rosas‐Vidal, L. E. , Lozada‐Miranda, V. , Cantres‐Rosario, Y. , Vega‐Medina, A. , Melendez, L. , & Quirk, G. J. (2018). Alteration of BDNF in the medial prefrontal cortex and the ventral hippocampus impairs extinction of avoidance. Neuropsychopharmacology in press, 43, 2636–2644.30127343
( Washbourne, P. (2015). Synapse assembly and neurodevelopmental disorders. Neuropsychopharmacology, 40, 4–15.24990427)
Washbourne, P. (2015). Synapse assembly and neurodevelopmental disorders. Neuropsychopharmacology, 40, 4–15.24990427
Washbourne, P. (2015). Synapse assembly and neurodevelopmental disorders. Neuropsychopharmacology, 40, 4–15.24990427, Washbourne, P. (2015). Synapse assembly and neurodevelopmental disorders. Neuropsychopharmacology, 40, 4–15.24990427
Haoran Wang, Shuyin Liang, J. Burgdorf, J. Wess, J. Yeomans (2008)
Ultrasonic Vocalizations Induced by Sex and Amphetamine in M2, M4, M5 Muscarinic and D2 Dopamine Receptor Knockout Mice
PLoS ONE, 3
( Vicidomini, C. , Ponzoni, L. , Lim, D. , Schmeisser, M. J. , Reim, D. , Morello, N. , … Verpelli, C. (2017). Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock‐out mice. Molecular Psychiatry, 22, 689–702.27021819)
Vicidomini, C. , Ponzoni, L. , Lim, D. , Schmeisser, M. J. , Reim, D. , Morello, N. , … Verpelli, C. (2017). Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock‐out mice. Molecular Psychiatry, 22, 689–702.27021819
Vicidomini, C. , Ponzoni, L. , Lim, D. , Schmeisser, M. J. , Reim, D. , Morello, N. , … Verpelli, C. (2017). Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock‐out mice. Molecular Psychiatry, 22, 689–702.27021819, Vicidomini, C. , Ponzoni, L. , Lim, D. , Schmeisser, M. J. , Reim, D. , Morello, N. , … Verpelli, C. (2017). Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock‐out mice. Molecular Psychiatry, 22, 689–702.27021819
( Muhle, A. , Reed, H. E. , Stratigos, K. A. , & Veenstra‐Vanderweele, J. (2018). The emerging clinical neuroscience of autism spectrum disorder: A review. JAMA Psychiatry, 75, 514–523.29590280)
Muhle, A. , Reed, H. E. , Stratigos, K. A. , & Veenstra‐Vanderweele, J. (2018). The emerging clinical neuroscience of autism spectrum disorder: A review. JAMA Psychiatry, 75, 514–523.29590280
Muhle, A. , Reed, H. E. , Stratigos, K. A. , & Veenstra‐Vanderweele, J. (2018). The emerging clinical neuroscience of autism spectrum disorder: A review. JAMA Psychiatry, 75, 514–523.29590280, Muhle, A. , Reed, H. E. , Stratigos, K. A. , & Veenstra‐Vanderweele, J. (2018). The emerging clinical neuroscience of autism spectrum disorder: A review. JAMA Psychiatry, 75, 514–523.29590280
( Wang, H. , Liang, S. , Burgdorf, J. , Wess, J. , & Yeomans, J. (2008). Ultrasonic vocalizations induced by sex and amphetamine in M2, M4, M5 muscarinic and D2 dopamine receptor knockout mice. PLoS One, 3, e1893.18382674)
Wang, H. , Liang, S. , Burgdorf, J. , Wess, J. , & Yeomans, J. (2008). Ultrasonic vocalizations induced by sex and amphetamine in M2, M4, M5 muscarinic and D2 dopamine receptor knockout mice. PLoS One, 3, e1893.18382674
Wang, H. , Liang, S. , Burgdorf, J. , Wess, J. , & Yeomans, J. (2008). Ultrasonic vocalizations induced by sex and amphetamine in M2, M4, M5 muscarinic and D2 dopamine receptor knockout mice. PLoS One, 3, e1893.18382674, Wang, H. , Liang, S. , Burgdorf, J. , Wess, J. , & Yeomans, J. (2008). Ultrasonic vocalizations induced by sex and amphetamine in M2, M4, M5 muscarinic and D2 dopamine receptor knockout mice. PLoS One, 3, e1893.18382674
T. Kazdoba, P. Leach, Mu Yang, J. Silverman, M. Solomon, J. Crawley (2016)
Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.
Current topics in behavioral neurosciences, 28
( Lynch, G. , Palmer, L. C. , & Gall, C. M. (2011). The likelihood of cognitive enhancement. Pharmacology, Biochemistry, and Behavior, 99, 116–129.)
Lynch, G. , Palmer, L. C. , & Gall, C. M. (2011). The likelihood of cognitive enhancement. Pharmacology, Biochemistry, and Behavior, 99, 116–129.
Lynch, G. , Palmer, L. C. , & Gall, C. M. (2011). The likelihood of cognitive enhancement. Pharmacology, Biochemistry, and Behavior, 99, 116–129., Lynch, G. , Palmer, L. C. , & Gall, C. M. (2011). The likelihood of cognitive enhancement. Pharmacology, Biochemistry, and Behavior, 99, 116–129.
M. Scattoni, A. Martire, G. Cartocci, A. Ferrante, L. Ricceri (2013)
Reduced social interaction, behavioural flexibility and BDNF signalling in the BTBR T+tf/J strain, a mouse model of autism
Behavioural Brain Research, 251
( Han, S. , Tai, C. , Jones, C. J. , Scheuer, T. , & Catterall, W. A. (2014). Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3‐subunits ameliorates behavioral deficits in a mouse model of autism. Neuron, 81, 1282–1289.24656250)
Han, S. , Tai, C. , Jones, C. J. , Scheuer, T. , & Catterall, W. A. (2014). Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3‐subunits ameliorates behavioral deficits in a mouse model of autism. Neuron, 81, 1282–1289.24656250
Han, S. , Tai, C. , Jones, C. J. , Scheuer, T. , & Catterall, W. A. (2014). Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3‐subunits ameliorates behavioral deficits in a mouse model of autism. Neuron, 81, 1282–1289.24656250, Han, S. , Tai, C. , Jones, C. J. , Scheuer, T. , & Catterall, W. A. (2014). Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3‐subunits ameliorates behavioral deficits in a mouse model of autism. Neuron, 81, 1282–1289.24656250
Mu Yang, J. Silverman, J. Crawley (2011)
Automated Three‐Chambered Social Approach Task for Mice
Current Protocols in Neuroscience, 56
( Blundell, J. , Blaiss, C. A. , Etherton, M. R. , Espinosa, F. , Tabuchi, K. , Walz, C. , … Powell, C. M. (2010). Neuroligin‐1 deletion results in impaired spatial memory and increased repetitive behavior. The Journal of Neuroscience, 30, 2115–2129.20147539)
Blundell, J. , Blaiss, C. A. , Etherton, M. R. , Espinosa, F. , Tabuchi, K. , Walz, C. , … Powell, C. M. (2010). Neuroligin‐1 deletion results in impaired spatial memory and increased repetitive behavior. The Journal of Neuroscience, 30, 2115–2129.20147539
Blundell, J. , Blaiss, C. A. , Etherton, M. R. , Espinosa, F. , Tabuchi, K. , Walz, C. , … Powell, C. M. (2010). Neuroligin‐1 deletion results in impaired spatial memory and increased repetitive behavior. The Journal of Neuroscience, 30, 2115–2129.20147539, Blundell, J. , Blaiss, C. A. , Etherton, M. R. , Espinosa, F. , Tabuchi, K. , Walz, C. , … Powell, C. M. (2010). Neuroligin‐1 deletion results in impaired spatial memory and increased repetitive behavior. The Journal of Neuroscience, 30, 2115–2129.20147539
( de Bartolomeis, A. , Latte, G. , Tomasetti, C. , & Iasevoli, F. (2014). Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: Relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for noveltherapeutic approaches. Molecular Neurobiology, 9, 484–511.)
de Bartolomeis, A. , Latte, G. , Tomasetti, C. , & Iasevoli, F. (2014). Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: Relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for noveltherapeutic approaches. Molecular Neurobiology, 9, 484–511.
de Bartolomeis, A. , Latte, G. , Tomasetti, C. , & Iasevoli, F. (2014). Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: Relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for noveltherapeutic approaches. Molecular Neurobiology, 9, 484–511., de Bartolomeis, A. , Latte, G. , Tomasetti, C. , & Iasevoli, F. (2014). Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: Relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for noveltherapeutic approaches. Molecular Neurobiology, 9, 484–511.
( Dhamne, S. C. , Silverman, J. L. , Super, C. E. , Lammers, S. H. T. , Hameed, M. Q. , Modi, M. E. , … Sahin, M. (2017). Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism. Molecular Autism, 8, 26.28638591)
Dhamne, S. C. , Silverman, J. L. , Super, C. E. , Lammers, S. H. T. , Hameed, M. Q. , Modi, M. E. , … Sahin, M. (2017). Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism. Molecular Autism, 8, 26.28638591
Dhamne, S. C. , Silverman, J. L. , Super, C. E. , Lammers, S. H. T. , Hameed, M. Q. , Modi, M. E. , … Sahin, M. (2017). Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism. Molecular Autism, 8, 26.28638591, Dhamne, S. C. , Silverman, J. L. , Super, C. E. , Lammers, S. H. T. , Hameed, M. Q. , Modi, M. E. , … Sahin, M. (2017). Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism. Molecular Autism, 8, 26.28638591
Jiseok Lee, Changuk Chung, Seungmin Ha, Dongmin Lee, Doyoun Kim, Hyun Kim, Eunjoon Kim (2015)
Shank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit
Frontiers in Cellular Neuroscience, 9
Q. Ren, Ji-chun Zhang, M. Ma, Yuko Fujita, Jin Wu, K. Hashimoto (2013)
7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine
Psychopharmacology, 231
K. Bales, M. Solomon, S. Jacob, J. Crawley, J. Silverman, Rebecca Larke, E. Sahagun, Kyle Puhger, M. Pride, S. Mendoza (2014)
Long-term exposure to intranasal oxytocin in a mouse autism model
Translational Psychiatry, 4
S. Moy, Jessica Nadler, N. Young, Antonio Perez, L. Holloway, R. Barbaro, Justin Barbaro, Lindsay Wilson, D. Threadgill, J. Lauder, Terry Magnuson, J. Crawley, J. Crawley (2007)
Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains
Behavioural Brain Research, 176
( Kouser, M. , Speed, H. E. , Dewey, C. M. , Reimers, J. M. , Widman, A. J. , Gupta, N. , … Powell, C. M. (2013). Loss of predominant Shank3 isoforms results in hippocampus‐dependent impairments in behavior and synaptic transmission. The Journal of Neuroscience, 33, 18448–18468.24259569)
Kouser, M. , Speed, H. E. , Dewey, C. M. , Reimers, J. M. , Widman, A. J. , Gupta, N. , … Powell, C. M. (2013). Loss of predominant Shank3 isoforms results in hippocampus‐dependent impairments in behavior and synaptic transmission. The Journal of Neuroscience, 33, 18448–18468.24259569
Kouser, M. , Speed, H. E. , Dewey, C. M. , Reimers, J. M. , Widman, A. J. , Gupta, N. , … Powell, C. M. (2013). Loss of predominant Shank3 isoforms results in hippocampus‐dependent impairments in behavior and synaptic transmission. The Journal of Neuroscience, 33, 18448–18468.24259569, Kouser, M. , Speed, H. E. , Dewey, C. M. , Reimers, J. M. , Widman, A. J. , Gupta, N. , … Powell, C. M. (2013). Loss of predominant Shank3 isoforms results in hippocampus‐dependent impairments in behavior and synaptic transmission. The Journal of Neuroscience, 33, 18448–18468.24259569
( McFarlane, H. G. , Kusek, G. K. , Yang, M. , Phoenix, J. L. , Bolivar, V. J. , & Crawley, J. N. (2008). Autism‐like behavioral phenotypes in BTBR T+tf/J mice. Genes, Brain, and Behavior, 7, 152–163.)
McFarlane, H. G. , Kusek, G. K. , Yang, M. , Phoenix, J. L. , Bolivar, V. J. , & Crawley, J. N. (2008). Autism‐like behavioral phenotypes in BTBR T+tf/J mice. Genes, Brain, and Behavior, 7, 152–163.
McFarlane, H. G. , Kusek, G. K. , Yang, M. , Phoenix, J. L. , Bolivar, V. J. , & Crawley, J. N. (2008). Autism‐like behavioral phenotypes in BTBR T+tf/J mice. Genes, Brain, and Behavior, 7, 152–163., McFarlane, H. G. , Kusek, G. K. , Yang, M. , Phoenix, J. L. , Bolivar, V. J. , & Crawley, J. N. (2008). Autism‐like behavioral phenotypes in BTBR T+tf/J mice. Genes, Brain, and Behavior, 7, 152–163.
B. Waszczak, R. Hruska, J. Walters (1980)
GABAergic actions of THIP in vivo and vitro: a comparison with muscimol and GABA.
European journal of pharmacology, 65 1
Luis Rosas-Vidal, Valeria Lozada-Miranda, Yisel Cantres-Rosario, Alexis Vega-Medina, L. Meléndez, G. Quirk (2018)
Alteration of BDNF in the medial prefrontal cortex and the ventral hippocampus impairs extinction of avoidance
Neuropsychopharmacology, 43
K. Chadman (2017)
Animal models for autism in 2017 and the consequential implications to drug discovery
Expert Opinion on Drug Discovery, 12
R. Olsen (2018)
GABAA receptor: Positive and negative allosteric modulators
Neuropharmacology, 136
( Crino, P. B. (2011). mTOR: A pathogenic signaling pathway in developmental brain malformations. Trends in Molecular Medicine, 17, 734–742.21890410)
Crino, P. B. (2011). mTOR: A pathogenic signaling pathway in developmental brain malformations. Trends in Molecular Medicine, 17, 734–742.21890410
Crino, P. B. (2011). mTOR: A pathogenic signaling pathway in developmental brain malformations. Trends in Molecular Medicine, 17, 734–742.21890410, Crino, P. B. (2011). mTOR: A pathogenic signaling pathway in developmental brain malformations. Trends in Molecular Medicine, 17, 734–742.21890410
R. Muhle, Hannah Reed, Katharine Stratigos, J. Veenstra-VanderWeele (2018)
The Emerging Clinical Neuroscience of Autism Spectrum Disorder: A Review
JAMA Psychiatry, 75
( Chadman, K. K. (2017). Animal models for autism in 2017 and the consequential implications to drug discovery. Expert Opinion on Drug Discovery, 12, 1187–1194.28971687)
Chadman, K. K. (2017). Animal models for autism in 2017 and the consequential implications to drug discovery. Expert Opinion on Drug Discovery, 12, 1187–1194.28971687
Chadman, K. K. (2017). Animal models for autism in 2017 and the consequential implications to drug discovery. Expert Opinion on Drug Discovery, 12, 1187–1194.28971687, Chadman, K. K. (2017). Animal models for autism in 2017 and the consequential implications to drug discovery. Expert Opinion on Drug Discovery, 12, 1187–1194.28971687
R. Pobbe, E. Defensor, B. Pearson, V. Bolivar, D., Caroline Blanchard, R. Blanchard (2011)
General and social anxiety in the BTBR T+ tf/J mouse strain
Behavioural Brain Research, 216
( Verpelli, C. , Dvoretskova, E. , Vicidomini, C. , Rossi, F. , Chiappalone, M. , Schoen, M. , … Sala, C. (2011). Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. The Journal of Biological Chemistry, 286, 34839–34850.21795692)
Verpelli, C. , Dvoretskova, E. , Vicidomini, C. , Rossi, F. , Chiappalone, M. , Schoen, M. , … Sala, C. (2011). Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. The Journal of Biological Chemistry, 286, 34839–34850.21795692
Verpelli, C. , Dvoretskova, E. , Vicidomini, C. , Rossi, F. , Chiappalone, M. , Schoen, M. , … Sala, C. (2011). Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. The Journal of Biological Chemistry, 286, 34839–34850.21795692, Verpelli, C. , Dvoretskova, E. , Vicidomini, C. , Rossi, F. , Chiappalone, M. , Schoen, M. , … Sala, C. (2011). Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. The Journal of Biological Chemistry, 286, 34839–34850.21795692
( Zhou, Y. , Kaiser, T. , Monteiro, P. , Zhang, X. , Van Der Goes, M. , Wang, D. , … Feng, G. (2016). Mice with Shank3 mutations associated with ASD and schizophrenia display both shared and distinct defects. Neuron, 89, 147–162.26687841)
Zhou, Y. , Kaiser, T. , Monteiro, P. , Zhang, X. , Van Der Goes, M. , Wang, D. , … Feng, G. (2016). Mice with Shank3 mutations associated with ASD and schizophrenia display both shared and distinct defects. Neuron, 89, 147–162.26687841
Zhou, Y. , Kaiser, T. , Monteiro, P. , Zhang, X. , Van Der Goes, M. , Wang, D. , … Feng, G. (2016). Mice with Shank3 mutations associated with ASD and schizophrenia display both shared and distinct defects. Neuron, 89, 147–162.26687841, Zhou, Y. , Kaiser, T. , Monteiro, P. , Zhang, X. , Van Der Goes, M. , Wang, D. , … Feng, G. (2016). Mice with Shank3 mutations associated with ASD and schizophrenia display both shared and distinct defects. Neuron, 89, 147–162.26687841
( Erickson, C. A. , Wink, L. K. , Early, M. C. , Stiegelmeyer, E. , Mathieu‐Frasier, L. , Patrick, V. , & McDougle, C. J. (2014). Brief report: Pilot single‐blind placebo lead‐in study of acamprosate in youth with autistic disorder. Journal of Autism and Developmental Disorders, 44, 981–987.24052275)
Erickson, C. A. , Wink, L. K. , Early, M. C. , Stiegelmeyer, E. , Mathieu‐Frasier, L. , Patrick, V. , & McDougle, C. J. (2014). Brief report: Pilot single‐blind placebo lead‐in study of acamprosate in youth with autistic disorder. Journal of Autism and Developmental Disorders, 44, 981–987.24052275
Erickson, C. A. , Wink, L. K. , Early, M. C. , Stiegelmeyer, E. , Mathieu‐Frasier, L. , Patrick, V. , & McDougle, C. J. (2014). Brief report: Pilot single‐blind placebo lead‐in study of acamprosate in youth with autistic disorder. Journal of Autism and Developmental Disorders, 44, 981–987.24052275, Erickson, C. A. , Wink, L. K. , Early, M. C. , Stiegelmeyer, E. , Mathieu‐Frasier, L. , Patrick, V. , & McDougle, C. J. (2014). Brief report: Pilot single‐blind placebo lead‐in study of acamprosate in youth with autistic disorder. Journal of Autism and Developmental Disorders, 44, 981–987.24052275
Stephan Sanders, Xin He, A. Willsey, A. Ercan-Sencicek, K. Samocha, A. Cicek, M. Murtha, V. Bal, S. Bishop, Shan Dong, A. Goldberg, Cai Jinlu, J. Keaney, L. Klei, Jeffrey Mandell, D. Moreno-De-Luca, Christopher Poultney, E. Robinson, L. Smith, Tor Solli-Nowlan, Mack Su, Nicole Teran, Michael Walker, Donna Werling, A. Beaudet, R. Cantor, E. Fombonne, D. Geschwind, D. Grice, C. Lord, J. Lowe, S. Mane, Donna Martin, E. Morrow, M. Talkowski, J. Sutcliffe, C. Walsh, T. Yu, D. Ledbetter, C. Martin, E. Cook, J. Buxbaum, M. Daly, B. Devlin, K. Roeder, M. State (2015)
Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci
Neuron, 87
S. Baudouin, Julien Gaudias, Stefan Gerharz, Laetitia Hatstatt, Kuikui Zhou, Pradeep Punnakkal, Kenji Tanaka, W. Spooren, R. Hen, C. Zeeuw, K. Vogt, P. Scheiffele (2012)
Shared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent Models of Autism
Science, 338
M. Ogier, Hong Wang, Elizabeth Hong, Qifang Wang, M. Greenberg, D. Katz (2007)
Brain-Derived Neurotrophic Factor Expression and Respiratory Function Improve after Ampakine Treatment in a Mouse Model of Rett Syndrome
The Journal of Neuroscience, 27
( Saarelainen, K. S. , Ranna, M. , Rabe, H. , Sinkkonen, S. T. , Möykkynen, T. , Uusi‐Oukari, M. , … Korpi, E. R. (2008). Enhanced behavioral sensitivity to the competitive GABA agonist, gaboxadol, in transgenic mice over‐expressing hippocampal extrasynaptic alpha6beta GABA(A) receptors. Journal of Neurochemistry, 105, 338–350.18021290)
Saarelainen, K. S. , Ranna, M. , Rabe, H. , Sinkkonen, S. T. , Möykkynen, T. , Uusi‐Oukari, M. , … Korpi, E. R. (2008). Enhanced behavioral sensitivity to the competitive GABA agonist, gaboxadol, in transgenic mice over‐expressing hippocampal extrasynaptic alpha6beta GABA(A) receptors. Journal of Neurochemistry, 105, 338–350.18021290
Saarelainen, K. S. , Ranna, M. , Rabe, H. , Sinkkonen, S. T. , Möykkynen, T. , Uusi‐Oukari, M. , … Korpi, E. R. (2008). Enhanced behavioral sensitivity to the competitive GABA agonist, gaboxadol, in transgenic mice over‐expressing hippocampal extrasynaptic alpha6beta GABA(A) receptors. Journal of Neurochemistry, 105, 338–350.18021290, Saarelainen, K. S. , Ranna, M. , Rabe, H. , Sinkkonen, S. T. , Möykkynen, T. , Uusi‐Oukari, M. , … Korpi, E. R. (2008). Enhanced behavioral sensitivity to the competitive GABA agonist, gaboxadol, in transgenic mice over‐expressing hippocampal extrasynaptic alpha6beta GABA(A) receptors. Journal of Neurochemistry, 105, 338–350.18021290
( Bollen, E. , Vanmierlo, T. , Akkerman, S. , Wouters, C. , Steinbusch, H. M. , & Prickaerts, J. (2013). 7,8‐Dihydroxyflavone improves memory consolidation processes in rats and mice. Behavioural Brain Research, 257, 8–12.24070857)
Bollen, E. , Vanmierlo, T. , Akkerman, S. , Wouters, C. , Steinbusch, H. M. , & Prickaerts, J. (2013). 7,8‐Dihydroxyflavone improves memory consolidation processes in rats and mice. Behavioural Brain Research, 257, 8–12.24070857
Bollen, E. , Vanmierlo, T. , Akkerman, S. , Wouters, C. , Steinbusch, H. M. , & Prickaerts, J. (2013). 7,8‐Dihydroxyflavone improves memory consolidation processes in rats and mice. Behavioural Brain Research, 257, 8–12.24070857, Bollen, E. , Vanmierlo, T. , Akkerman, S. , Wouters, C. , Steinbusch, H. M. , & Prickaerts, J. (2013). 7,8‐Dihydroxyflavone improves memory consolidation processes in rats and mice. Behavioural Brain Research, 257, 8–12.24070857
Wenting Wang, Chen-chen Li, Qian Chen, Marie-Sophie Goes, James Hawrot, Annie Yao, Xian Gao, Congyi Lu, Ying Zang, Qiangge Zhang, K. Lyman, Dongqing Wang, B. Guo, Shengxi Wu, C. Gerfen, Z. Fu, G. Feng (2017)
Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism
Journal of Clinical Investigation, 127
( Steinmetz, A. B. , Stern, S. A. , Kohtz, A. S. , Descalzi, G. , & Alberini, C. M. (2018). Insulin‐like growth factor II targets the mTOR pathway to reverse autism‐like phenotypes in mice. The Journal of Neuroscience, 38, 1015–1029.29217683)
Steinmetz, A. B. , Stern, S. A. , Kohtz, A. S. , Descalzi, G. , & Alberini, C. M. (2018). Insulin‐like growth factor II targets the mTOR pathway to reverse autism‐like phenotypes in mice. The Journal of Neuroscience, 38, 1015–1029.29217683
Steinmetz, A. B. , Stern, S. A. , Kohtz, A. S. , Descalzi, G. , & Alberini, C. M. (2018). Insulin‐like growth factor II targets the mTOR pathway to reverse autism‐like phenotypes in mice. The Journal of Neuroscience, 38, 1015–1029.29217683, Steinmetz, A. B. , Stern, S. A. , Kohtz, A. S. , Descalzi, G. , & Alberini, C. M. (2018). Insulin‐like growth factor II targets the mTOR pathway to reverse autism‐like phenotypes in mice. The Journal of Neuroscience, 38, 1015–1029.29217683
( Olson, R. W. (2018). GABAA receptor: Positive and negative allosteric modulators. Neuropharmacology, 136, 10–22.29407219)
Olson, R. W. (2018). GABAA receptor: Positive and negative allosteric modulators. Neuropharmacology, 136, 10–22.29407219
Olson, R. W. (2018). GABAA receptor: Positive and negative allosteric modulators. Neuropharmacology, 136, 10–22.29407219, Olson, R. W. (2018). GABAA receptor: Positive and negative allosteric modulators. Neuropharmacology, 136, 10–22.29407219
R. Pobbe, B. Pearson, E. Defensor, Valerie Bolivar, D., Caroline Blanchard, Robert Blanchard (2010)
Expression of social behaviors of C57BL/6J versus BTBR inbred mouse strains in the visible burrow system
Behavioural Brain Research, 214
( Lemonnier, E. , Degrez, C. , Phelep, M. , Tyzio, R. , Josse, F. , Grandgeorge, M. , … Ben‐Ari, Y. (2012). A randomised controlled trial of bumetanide in the treatment of autism in children. Translational Psychiatry, 2, e202.23233021)
Lemonnier, E. , Degrez, C. , Phelep, M. , Tyzio, R. , Josse, F. , Grandgeorge, M. , … Ben‐Ari, Y. (2012). A randomised controlled trial of bumetanide in the treatment of autism in children. Translational Psychiatry, 2, e202.23233021
Lemonnier, E. , Degrez, C. , Phelep, M. , Tyzio, R. , Josse, F. , Grandgeorge, M. , … Ben‐Ari, Y. (2012). A randomised controlled trial of bumetanide in the treatment of autism in children. Translational Psychiatry, 2, e202.23233021, Lemonnier, E. , Degrez, C. , Phelep, M. , Tyzio, R. , Josse, F. , Grandgeorge, M. , … Ben‐Ari, Y. (2012). A randomised controlled trial of bumetanide in the treatment of autism in children. Translational Psychiatry, 2, e202.23233021
( Björkholm, C. , & Monteggia, L. M. (2016). BDNF ‐ A key transducer of antidepressant effects. Neuropharmacology, 102, 72–79.26519901)
Björkholm, C. , & Monteggia, L. M. (2016). BDNF ‐ A key transducer of antidepressant effects. Neuropharmacology, 102, 72–79.26519901
Björkholm, C. , & Monteggia, L. M. (2016). BDNF ‐ A key transducer of antidepressant effects. Neuropharmacology, 102, 72–79.26519901, Björkholm, C. , & Monteggia, L. M. (2016). BDNF ‐ A key transducer of antidepressant effects. Neuropharmacology, 102, 72–79.26519901
( Jaramillo, T. C. , Speed, H. E. , Xuan, Z. , Reimers, J. M. , Liu, S. , & Powell, C. M. (2016). Altered striatal synaptic function and abnormal behaviour in Shank3 exon4‐9 deletion mouse model of autism. Autism Research, 9, 350–375.26559786)
Jaramillo, T. C. , Speed, H. E. , Xuan, Z. , Reimers, J. M. , Liu, S. , & Powell, C. M. (2016). Altered striatal synaptic function and abnormal behaviour in Shank3 exon4‐9 deletion mouse model of autism. Autism Research, 9, 350–375.26559786
Jaramillo, T. C. , Speed, H. E. , Xuan, Z. , Reimers, J. M. , Liu, S. , & Powell, C. M. (2016). Altered striatal synaptic function and abnormal behaviour in Shank3 exon4‐9 deletion mouse model of autism. Autism Research, 9, 350–375.26559786, Jaramillo, T. C. , Speed, H. E. , Xuan, Z. , Reimers, J. M. , Liu, S. , & Powell, C. M. (2016). Altered striatal synaptic function and abnormal behaviour in Shank3 exon4‐9 deletion mouse model of autism. Autism Research, 9, 350–375.26559786

Publisher: Wiley
ISSN: 1939-3792
eISSN: 1939-3806
DOI: 10.1002/aur.2066
Publisher site: See Article on Publisher Site

Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Hypothesis‐driven investigations of diverse pharmacological targets in two mouse models of autism

Hypothesis‐driven investigations of diverse pharmacological targets in two mouse models of autism

Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Hypothesis‐driven investigations of diverse pharmacological targets in two mouse models of autism

Hypothesis‐driven investigations of diverse pharmacological targets in two mouse models of autism

References (248)

Abstract

Journal

Recommended Articles

There are no references for this article.

Our policy towards the use of cookies